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MULTI-MODALITY AUTOMATIC LUNG TUMOR SEGMENTATION
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By Siqiu Wang
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Director: Lulin Yuan,
Assistant Professor, Department of Radiation Oncology

Delineation of the tumor volume is the initial and fundamental step in the
radiotherapy planning process. The current clinical practice of manual delineation is
time-consuming and suffers from observer variability. This work seeks to develop an
effective automatic framework to produce clinically usable lung tumor segmentations.
First, to facilitate the development and validation of our methodology, an expansive
database of planning CTs, diagnostic PETs, and manual tumor segmentations was
curated, and an image registration and preprocessing pipeline was established. Then a
deep learning neural network was constructed and optimized to utilize dual-modality
PET and CT images for lung tumor segmentation. The feasibility of incorporating
radiomics and other mechanisms such as a tumor volume-based stratification scheme
for training/validation/testing were investigated to improve the segmentation
performance. The proposed methodology was evaluated both quantitatively with

similarity metrics and clinically with physician reviews. In addition, external validation
with an independent database was also conducted.
Our work addressed some of the major limitations that restricted clinical applicability
of the existing approaches and produced automatic segmentations that were consistent
with the manually contoured ground truth and were highly clinically-acceptable according
to both the quantitative and clinical evaluations. Both novel approaches of implementing
a tumor volume-based training/validation/ testing stratification strategy as well as
incorporating voxel-wise radiomics feature images were shown to improve the
segmentation performance. The results showed that the proposed method was effective
and robust, producing automatic lung tumor segmentations that could potentially
improve both the quality and consistency of manual tumor delineation.

A. Introduction
Within the last decade, applications of machine learning, deep learning in particular,
has gained enormous momentum in cancer research due to a combination of the
increasing availability of life sciences data and the soaring demand for more precise and
individualized medicine. Cancer genome and pathology research, as outstanding
examples, benefited tremendously from automated microscopy and tissue labelling as
well as the establishment of public databases such as the Cancer Genome Atlas that
currently houses over 2.5 petabytes of high-quality data. In comparison, applications of
automated image segmentation for the purpose of radiotherapy planning have not
experienced the same degree of acceleration. While several vendors have developed
software products for normal organ segmentation as well as adaptations of the existing
tumor segmentations based on deformable registration, accurate automatic generation
of the initial tumor segmentation has proven to be challenging and left many avenues to
be explored. Despite many methods have been proposed, the uniqueness of each
cancer case combined with the limited access to well-labeled imaging data, due to
patient privacy and HIPAA concerns, is a major hurdle to adequate validation and
subsequently clinical deployment.
This work aims to combine novel techniques with thorough validation to construct an
automated tumor segmentation framework that produce clinically meaningful results.

A.1 Non-Small Cell Lung Cancer
Lung cancer is the second most common cancer in both men and women, and by far
the leading cause of cancer mortality, accounting for 23% of all cancer deaths in the United
States. About 80-85% of the lung cancers diagnosed are Non-Small Cell Lung Cancer
(NSCLC) which is the main focus of this study [1]. Unfortunately, the overall 5-year survival

rate for all stages of lung cancer is only 22.9%. While only about 16% of lung cancer cases
are diagnosed at a localized stage, the five-year survival rate for these patients is at a
much higher 61.2% [2]. As the primary definitive treatment for patients with locally
advanced lung cancer and inoperable patients with early stage lung cancer [3], external
beam radiation therapy is the treatment modality-of-choice for tumors of a broad range of
sizes, locations, and complexities. Improving the effectiveness of radiotherapy is an
important aspect of enhancing lung cancer care.

A.2 Lung Cancer Radiotherapy Workflow and Its Uncertainties
The fundamental principle of radiation therapy is the delivery of a cell-killing high dose
to the tumor and the sparing of the surrounding normal tissues according to their specific
dose tolerances. Achieving this goal with great precision requires the minimization of
uncertainties throughout the radiotherapy process. A standard-of-care radiation treatment
for lung cancer involves two phases: planning and delivery. The general workflow can be
summarized as the following steps:
1. Diagnosis and clinical workups
2. Consultation and assessment for radiation treatment
3. Simulation
4. Target volume and organs at risk delineation
5. Dose prescription and treatment planning
6. Treatment setup and delivery
The cancer treatment planning phase (step 1 to 5) begins when radiation therapy is
chosen as the treatment modality based on diagnosis, patient consultation, and
assessment for suitability. A set of CT images specifically needed for planning purposes

is then acquired during simulation where the patient is immobilized and positioned under
the treatment conditions. These planning CTs, along with the PET/CTs or diagnostic CTs
taken during the clinical workups, are used for volume delineation where the volumes of
interest, i.e., the target for dose delivery and the organs-at-risk for avoidance, are
contoured. With these images and delineated volumes as basis, a radiation treatment plan
is constructed and optimized in the treatment planning system (TPS) that outlines the
desired dose distribution according to the prescribed dose and the instructions for the
treatment machine to deliver such distribution.
According to the International Atomic Energy Agency (IAEA) report on accuracy and
uncertainties in radiotherapy [4], planning uncertainties mostly arise from the volume
delineation step which has been recognized as “the weakest link in the search for accuracy
in radiotherapy” [5], as will be discussed in detail in the next section. To a lesser extent,
uncertainty in the treatment planning system due to relative dose calibration, dose
calculation algorithms, and plan-to-deliverable optimization also affect the accuracy.
A treatment plan is normally delivered in multiple irradiation fractions. At the beginning
of each fraction, the patient is positioned and immobilized at the treatment machine using
the same setup as in simulation with the guidance of the on-board imaging systems. The
fractional dose distribution is then delivered according to the TPS-generated plan. This
process is repeated until the entire treatment course is completed.
The International Commission on Radiation Units and Measurements (ICRU) [6]
recognizes three main sources of uncertainty in the delivery phase that may impact the
precise execution of a plan: patient setup, organ motion and/or deformation, and machine
errors. Patient setup variations from fraction to fraction are unavoidable, even though
immobilization devices and on-board imaging guidance are employed to improve
positioning reproducibility. Depending on the specific tumor site, organ motion can have a

varying degree of influence on the consistency of plan delivery. Bladder or rectum fillings
can cause inter-fractional variations, while bowel movement, cardiac, or respiratory motion
leads to intra-fractional variations. Motion management measures are often adopted to
mitigate these effects. Treatment machine-related uncertainties are often not considered
significant, with the advent of modern engineering enabling high mechanical accuracy
(e.g., mechanical center vs. radiation center, multi-leaf collimator (MLC) positioning, etc.)
as well as dosimetric accuracy (e.g., accumulated dose, dose delivery rate, dose gradient,
etc.).
Furthermore, imaging is utilized throughout the entire treatment process: PET/CT
acquired during clinical workups and CT during simulation are used for planning; planar
x-ray as well as cone-beam CT (CBCT) taken with the on-board imagers are essential for
patient setup. The limitations of these systems also introduce uncertainty to the process.
Ideally, efforts should be made to keep all uncertainties as low as possible. In practice,
the IAEA report provided estimates of the levels of accuracy that are clinically achievable
(Table 1).
Table 1. Estimates of external beam radiation therapy related uncertainties. The contents are
adapted from the IAEA report to focus on lung cancer treatment only.
Quantity

Dosimetric
Uncertainty*

Planning
Dose calibration
Imaging related to treatment planning
CT
Image geometry & resolution
PET
Image geometry & resolution
Volume delineation
Target definition (site dependent)
Normal tissue definition
Treatment planning system

1.6–2.6%

< 2 mm
4–7 mm
5–50 mm
5–20 mm
Several % *

Delivery

Geometric
Uncertainty

2–4 mm

Treatment machine related uncertainties
Mechanical
Dosimetric
Patient positioning
Initial setup
Re-setup at each fraction
Imaging related to delivery
EPIDs
Image geometry & resolution
MV CT (helical)
Image geometry & resolution
kV CBCT
Image geometry & resolution
MV CBCT
Image geometry & resolution
Overall
EBRT end to end in phantom **
EBRT end to end in patient ** #

< 2 mm
< 2%
< 1–15 mm
2–5 mm

1–2 mm
1–2 mm
1 mm
2 mm
3–10%
5–10%

2 mm
5 mm

* TPS uncertainties can reach up to 20% in regions of high density heterogeneity, especially
with older systems. However, this is not typically a concern in lung cancer treatment. ** Does not
include volume delineation. # Expert consensus.

A.3 Lung Tumor Delineation and Observer Variability
A.3.1 Lung Tumor Delineation Workflow
Without an invasive and thorough pathological investigation, it is difficult to determine
the “true” extent of the disease. Instead, manual delineation by radiation oncologists based
on medical images is considered the “ground truth” in current clinical practice. Manual
delineation is one of the most laborious and time-consuming tasks for physicians in the
treatment planning process [7].
Compared with the other geometric uncertainties, volume delineation uncertainty is
evidently much more significant (Table 1). Target delineation, specifically, is one of the
most error-prone steps in the radiotherapy chain. Figure 1 briefly summarizes the

workflow and the types of medical images commonly employed for lung tumor
delineation.

Figure 1. An example of the image modalities involved in lung radiotherapy. A diagnostic set of
CT (a) and PET (b) are first acquired on a PET/CT scanner; Information from the fused PET/CT
image (c) and the planning CT (d), taken during the simulation, are then combined (through either
visual inspection or PET/CT and CT fusion) and assessed by the radiation oncologist who
delineates the target volumes (GTV, CTV, and PTV) on the planning CT (e).

Since the defined volumes are the basis on which the treatment plan is constructed,
any inaccuracy will lead to a systematic error downstream, potentially resulting in a
geographical miss of the target and/or overexposure of the organs-at-risk. To provide a
uniform framework for delineation, ICRU introduced the concepts of gross tumor volume
(GTV), clinical target volume (CTV), and planning target volume (PTV) [8] (Figure 1.e). In
summary, GTV envelopes the gross palpable or visible extent of the malignant growth
which includes the primary tumor, any metastatic lymph nodes, and other metastasis. CTV
expands upon the GTV to contain the microscopic disease that is not visible to the naked
eyes, whereas PTV includes the CTV and a margin to account for organ motion and setup

variation. While the contouring and margin selection for CTV and PTV is a topic that
warrants extensive investigation, our project will focus mainly on the delineation of GTV.
There are two interplaying sources of variations in target volume delineation: 1)
uncertainty due to the inherent limitations of the imaging modalities, especially in capturing
the metastatic disease and 2) the observer variability in the determination of the exact
GTV boundary from the images [9].

A.3.2 Imaging-Related Uncertainty
The delineation process is subject to both the strengths and pitfalls of the imaging
modalities. For lung tumor delineation, radiation oncologists mainly rely on two types of
images: CT (Figure 1.a) and PET (Figure 1.b). The image acquisition mechanisms of
these two modalities are fundamentally different: A CT image is the volumetric
reconstruction of the transmission of x-rays from the generator through the patient to the
detectors, whereas PET depends on the detection and localization of the annihilation
photons produced by the positron-emitting radiotracer injected into the patient’s body. As
a result, CT depicts the anatomical structures according to their electron density, while the
signal in PET reflects the radiotracer uptake in the local tissue. In the case of FDG-PET,
the radiotracer 18F-FDG congregates in the regions of high glucose consumption, i.e. high
metabolic activity. Since malignant lesions tend to be metabolically active,
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lung cancer imaging is especially useful in identifying metastatic lymph nodes or the
primary tumor boundary especially at ambiguous tumor/normal tissue interfaces [10].
The anatomical and functional information from CT and PET, respectively, are
complimentary to each other. During diagnosis/staging, a PET image is usually acquired
alongside a CT image on a PET/CT scanner with the patient in the same position for
anatomical reference and attenuation correction. The images are registered upon

acquisition, forming a set of PET/CT image. Incorporating PET/CT along with the
simulation CT in target volume delineation was shown to alter the shape and size of the
GTVs in a majority of patients undergoing radiotherapy with curative intent [11]. A
multitude of studies have demonstrated the advantage of combining PET and CT over the
conventional CT-only planning in improving GTV coverage and changing the size of GTVs,
thus enabling target dose escalation while complying with the constraints for organs-atrisk [12]. A systematic study found that the percentage of cases where the integration of
PET/CT in radiotherapy planning led to significant changes in the delineated target
volumes ranged from 21% to 100% among all reviewed studies [13]. Furthermore, PET is
invaluable in delimiting a rough boundary between the tumor and its surrounding tissues
when they appear indistinguishable on CT due to their similar electron densities [14]. In
the area of atelectasis, especially, incorporating PET/CT was shown to successfully
reduce the lung and esophageal doses while maintaining target coverage [15].
However, while the adaptation of multi-modality treatment planning helps accurately
define the target volumes, it also introduces additional uncertainties due to a few clinical
and technical issues: how to reliably define the tumor boundary in PET and how to
combine PET/CT and planning CT for composite delineation.
The tumor/normal tissue boundary on PET is often difficult to pinpoint because of the
low spatial resolution and the variations in signal intensity thresholds used for determining
active tumor disease. Modern PET/CT scanners in the clinics can achieve spatial
resolution of less than 2 mm for CT and up to 7 mm for PET (Table 1). In addition to the
inherent low spatial resolution due to its acquisition mechanism, PET also suffers from
motion artifacts since the images are taken under free-breathing conditions and take
several minutes. Furthermore, since the radiotracer uptake in tissue is governed by a
variety of biological and physical processes that vary from patient to patient. there does

not exist a physically meaningful PET signal threshold between malignant lesions and
normal tissue [16]. The simplest way to utilize PET information is visual interpretation.
However, the apparent tumor volume is significantly affected by the window level and
therefore highly subjective. Alternatively, the standardized uptake value (SUV) was coined
in an attempt to standardize the signal intensity and provide a semi-quantitative basis for
evaluation. SUV is a measure of radiotracer uptake activity in a region of interest (ROI)
normalized to a distribution volume. An arbitrary SUV value (2.0 to 2.5) or a percentage
of SUVmax (40% to 50%) is often used to distinguish between normal and abnormal tissues
[12], [17]. However, the clinical validity of SUV thresholds has been repeatedly challenged.
Biehl et al. argued that the optimal threshold for delineation depends on the tumor size
and can range from 15  6% for large tumors to 42  2% for tumors smaller than 3 cm [18].
Biological factors such as heterogeneous uptake, inflammation, blood glucose level,
motion artifacts, etc. and technical factors such as scanner variability, reconstruction
parameter, residual activity in the system, etc. all may affect SUV calculations by 5% to
50% [19]. PET/CT for lung cancer faces additional challenge, as respiration-induced
misalignments between PET and CT within a single PET/CT scan can lead to a significant
underestimation of the SUV as the CT is the basis of attenuation correction in PET [20].
In summary, tumor edge definition in PET is challenging and leaves a wide gap for
subjective user interpretation. Minimizing this subjectivity is one of the driving forces
behind automated computer vision methods where the full range of voxel intensity can be
utilized quantitatively instead of a single threshold.
Once the PET/CT and planning CT are acquired, how to combine the information from
these two distinct modalities for volume delineation introduces new variables due to the
lack of strict clinical guidelines [21]. In the most direct approach, as in our institution, the
diagnostic PET/CT is displayed in fused mode (Figure 1.c) next to the planning CT (Figure

1.d). The two images are then visually correlated by the radiation oncologist who
delineates the GTV on the planning CT while identifying areas of active malignant lesions
on PET/CT for inclusion into the GTV (Figure 1.e). The association of information in this
method relies on the radiation oncologist’s knowledge and experience and is therefore
prone to observer variability. Instead of visual referencing, image fusion is sometimes
applied [22]. However, differences in image acquisition conditions between the diagnostic
PET/CT and the simulation CT, along with organ movement and respiratory motion, can
make registration difficult, potentially leading to interpretation issues and increased
observer variability [23]. Deformable registration has been a candidate in addressing
differences in acquisition conditions in other applications such as treatment response
assessment. However, it was to be of marginal value for treatment planning [24]. There is
not yet a unified strategy to level PET and CT images for manual delineation of lung tumor,
which contributes to the uncertainty in volume delineation.

A.3.3 Observer-Related Uncertainty
Some of these limitations can be addressed through following delineation protocols
and utilizing technological advancements of the imaging modalities, e.g. more
sophisticated detection system to achieve higher PET resolution, dedicated PET/CT
simulator to reduce registration mismatch, etc. However, even with a consistent imaging
and delineation protocol as well as a matching set of PET/CT and planning CT, observer
variability persists as the main source of geometric uncertainty compared with setup error
and organ motion [25]. As a visual example, 6 physicians from our institution delineated
the GTV (Figure 2) for the same patient using the same set of PET/CT and planning CT.
Although the metrics used in literature to quantify inter- and intra-observer variability in
lung tumor delineation are not uniform, the general findings indicate a significant level of

observer-related uncertainty. The Vmax/Vmin ratio among GTVs delineated by different
radiation oncologists for the same patient can range from 1.8 to 2.3 for the primary GTV
and from 5.2 to > 7 for the nodal GTV [26]. Fox et al. reported a median interobserver
percentage of concordance of 70% and a median intraobserver percentage of
concordance of 71% using registered PET/CT and planning CT (an improvement from 61%
and 58%, respectively, with unregistered images) [27]. Louie et al. found that 4D-CT may
help reduce both inter- and intra-observer variabilities. However, disagreement among
observers tends to increase with case complexity with the reported primary tumor volume
overlap index ranging from 0.556 to 0.915 [28]. The location of the tumor and the type of
interface between the tumor and the surrounding tissue were shown to be important
factors associated with the degree of observer variability [29]. Karki et al. found the
variability at tumor-atelectasis interface to be significantly larger than that at any other
interfaces. In general, a thorough review of interventions to reduce inter-observer
variability [30] attributed the wide-spread variability to the difference in knowledge (both
oncological and anatomical) and its application, interpretation of anatomy on images, as
well as understanding of target volume definitions. In addition, each physician’s
risk/benefit assessment, especially in regions of anatomical ambiguity, also impact the
decision making process [9]. Methodological differences such as drawing precision and
hand-eye coordination may also play a role in executing the intended target volume [26].
Addressing the observer variability stemming from the differences in subjective
interpretation is essential to improving the quality and consistency of lung cancer
treatment.

Figure 2. An example of inter-observer variability in manual segmentation. The figure shows 6
different GTVs delineated by 6 different radiation oncologists from our institution.

A.3.4 Metrics for Tumor Delineation Evaluation
A wide variety of metrics was used for volume delineation comparison among literature,
which sometimes makes it difficult to directly compare studies. There are different quality
aspects in 3D medical image segmentation according to which types of segmentation
errors can be defined. Metrics are expected to discern some or all of these errors,
depending on the data and the segmentation task. Comprehensive overviews of
volumetric comparison methods have previously been published [31]. Generally speaking,
the metrics are grouped into volumetric comparisons (volume measurements, volume
ratios), measures of overlap (concordance, discordance, Dice similarity Coefficient),
surface or dimension measures (dimensions, mean surface distance, Hausdorff distance)
and center of volume or mass [32]. For the purpose of delineation/segmentation
performance assessment, measures of overlap appear to be the most common.
The Dice coefficient (DSC), also called the overlap index, is the most used metric in
validating medical volume segmentations. In addition to the direct comparison between

automatic and ground truth segmentations, it is common to use the DICE to measure
reproducibility (repeatability). DSC is defined by

𝐷𝑆𝐶 =

2|𝑆𝑔 ⋂ 𝑆|
|𝑆𝑔 | + |𝑆|

where Sg is the “ground-truth” segmentation and S is the segmentation to be assessed.
DSC is also proficient at dealing with situations where there is a strong imbalance between
the number of foreground and background voxels, which is the case in tumor volume
segmentation where the volumes of normal tissue far out weight that of the targets.
For surface-specific assessment, Karki et al. adopted the bidirectional local distance
(BLD) as a measure for inter-observer variability [33]. BLD was shown to be more effective
than conventional distance measures (e.g., minimum distance) in the presence of complex
tumor contours by taking into account the bidirectional characteristics of minimum surfaceto-point distance with both forward and backward search directions. BLD can be applied
near round concave or folding regions for surface-specific analysis of segmentation
performance.
The ultimate goal of a segmentation framework is clinical utility; therefore, a clinical
acceptance task is essential. Gooding et al. presented a methodology inspired by the
Turing Test [34] provided a framework for assessing automatic segmentation performance.
This approach argues that if trained human observers are unable to distinguish the
automatic segmentation from those manually-delineated by the clinicians, then the
machine-generated segmentations are of sufficient quality for clinical use. This framework
can be adapted into a clinical acceptability test where physicians will be asked to rate or
select a collection of manual and automatic tumor contours.

A.4 Previous Automatic Lung Tumor Segmentation Methods
Previous publications have proposed a variety of PET and CT lung tumor cosegmentation methods using 1) traditional graphical models and variational methods, 2)
supervised and unsupervised machine learning, or a mixture of 1) and 2). There are two
main considerations: how to effectively incorporate the data from both PET and CT, and
how to perform segmentation accurately and efficiently.
Traditional graph theory-based methods are intuitive and computationally efficient.
More importantly, they are able to achieve competitive performance without consuming a
large amount of data. Bagci et al. represented the PET and CT images in a product lattice,
essentially making a hyper graph, and performed simultaneous delineation using the
random walk (RW) algorithm [35]. Ju et al. formulated the RW segmentation on PET and
graph cut segmentation on CT as a single energy minimization problem [36]. Under a
Bayesian framework, Irace and Batatia [37] proposed to combine the PET and CT data
using a bivariate Poisson mixture model. Markov random field optimization has also been
previously employed for PET/CT co-segmentation [38]. More recently, Cui et al. [39]
adopted a modified RW framework where a topology graph was generated from the PET
images that applied spatial-topological constraints in addition to the local intensity changes
from CT. The main disadvantage of the traditional graph theory is that in most of these
approaches, at least one user-defined seed or ROI is needed to establish the baseline for
segmentation, which means the process cannot be fully automated. Although a method to
automatically select object/background seed was discussed in [35], the approach is prone
to non-tumor uptake and requires a pre-defined signal threshold. Furthermore, graphbased theory tends to fare poorly at tumor and normal tissue interfaces when signal
intensity changes are subtle due to the lack of complex spatial context. Decisions are

made only according to the information provided by intensity values of image voxels, while
other imaging features such as texture are ignored.
Machine learning has seen increasing popularity in a wide range of medical image
processing tasks including automatic tumor segmentation. Earlier works such as Kawata
et al. [40] and Ikushima et al. [41] investigated the efficacy of automated frameworks based
on traditional neural networks: fuzzy-c-means clustering method (FCM), artificial neural
network (ANN), and support vector machine (SVM). These two studies followed the clinical
protocol of radiotherapy planning by using the planning CT as well as the diagnostic
PET/CT with the manual delineations by radiation oncologists as the ground truth.
However, the databases were limited (< 20 patients), and the authors offered few details
on the network designs, so it was difficult to determine the validity of these methods. It
was also reported that the segmentation performance was highly dependent on tumor
texture (solid, ground glass opacity, and part-solid ground glass opacity).
The majority of earlier reports on deep learning-based methods for lung tumor
segmentation focused on a single imaging modality, i.e., CT,[42]–[46] omitting the
complemental information provided by functional imaging modalities such as PET. In the
last few years, dual-modality methods had begun to gain traction, and several methods
were developed to automatically segment lung tumors using PET and CT inputs, with
different approaches on how to effectively incorporate the data from both modalities. A
summary of the databases and the DSCs of these works, including the two traditional ML
methods, is provided in Table 2. Most of these works employed some variations of U-Net
[47] and its 3D adaptation V-Net [48] due to the network architecture’s ability to efficiently
segment images using relatively small datasets, and the segmentation performance was
shown to improve over previous non-machine learning-based methods [49], [50]. One
main approach is to process the PET and CT images in parallel. Both Zhong et al. [51]

and Zhao et al. [49] utilized two independent V-Nets to extract features from PET and CT.
While Zhong et al. performed a graph-cut co-segmentation using the two sub-network
outputs as region costs, Zhao et al. fused the outputs of the two V-Nets through elementwise sum and fed the combined image into another CNN, functioning as a feature fusion
module, to produce the final tumor mask. In another paper, Zhong et al. [52] proposed a
network with two independent convolutional arms as well as two deconvolutional arms for
simultaneous co-segmentation in the PET and CT images. Kumar et al. [53] constructed
a variation of V-Net where the independently extracted PET and CT features were fused
at each resolution level through elementwise multiplication with a co-learned fusion weight
map. Arguing that the fusion of image features can be further improved through
progressive phases, Bi et al. [54] proposed the addition of a recurrent fusion network (RFN)
to the convolutional network backbones. Alternatively, some other works chose to utilize
the two modalities sequentially. Fu et al. [55] used the U-Net to extract a spatial attention
map from the PET image, which is then incorporated into another U-Net where the tumor
segmentation is produced on the corresponding CT image. Li et al. [56] combined deep
learning with a variational method by creating a tumor probability map from the CT image
with a fully-convolutional network (FCN) and using a fuzzy variational model to segment
the tumor from the combination of the probability map and the PET image.
On a completely different note with unsupervised learning, Lian et al. [50] devised a
co-clustering algorithm where the data from PET and CT are modeled and fused based
on the theory of belief function, a tool for representing and reasoning with uncertainty and
probability.
While DSC values from 0.64 to 0.87 were reported in the previous deep learningbased works, the results of these studies were not directly comparable with either our
method or among each other due to missing information on the quality of the databases,

the lack of sufficient validation, as well as the discrepancy in how the ground truth was
defined in each study. All previous networks were investigated with limited cohorts of
<100 cases [40], [41], [49]–[56] and used a variety of methods for to define the ground
truth (SUV threshold-based [53]–[55], manual in PET and/or CT [49]–[52], [54], or the
contours used in the clinical plans [40], [41]). In most reports, tumor specifics (size,
stage, location, etc.) were not identified. In addition, there was a general lack of a clear
validation scheme. The terms “validation” and “testing” were sometimes used
interchangeably, and several papers used their testing datasets during the development
of their networks [52], [56], [57]. Furthermore, no clinical validation or validation with an
external database were conducted to our knowledge. As a result, it is difficult to compare
the performance of different methods using the reported evaluation metrics. For
example, Zhong et al. [51] reported DSCs of 0.87 ± 0.05 (vs. manual ground truth on
CT) and 0.76 ± 0.09 (vs. manual ground truth on PET), the adaptation of this method by
Kumar et al. [53] on their database only achieved a DSC of 0.63 (using 40% peak SUV
on PET for initial contour with manual adjustments on CT).
Importantly, all previous works in deep learning-based lung tumor segmentation[49]–
[53], [55] used the pre-registered diagnostic PET/CT images without incorporating the
simulation CT that is the basic modality for radiation treatment planning, ignoring any
uncertainties introduced by PET and simulation CT registration for a valid clinical scenario.

Table 2. Summary of the previous works in machine learning-based dual-modality automatic lung tumor segmentation.

Author
(Year)
Kawata [40]
(2017)
Ikushima [41]
(2016)
Zhong [51]
(2018)
Zhong [52]
(2019)
Zhao [49]
(2018)
Kumar [53]
(2019)
Lian [50]
(2019)
Fu [55]
(2020)
Li [56]
(2020)
Bi [54]
(2021)

Image
Type

Database

Validation/Testing

3D

16 SBRT
**

N/A

3D

14 SBRT

PET/CT

3D

32

PET/CT

3D

60

PET/CT

3D

84

PET/CT

2D

50

PET/CT

3D

21

PET/CT

2D

50

PET/CT

3D

84

PET/CT

2D

50, 70
***

Modalities
Planning
CT*, PET/CT
Planning CT,
PET/CT

Leave-one-out-bypatient
Training: 20
Testing: 12
Training: 38
Validation/Testing: 22
Training: 48
Testing: 36
5-fold Validation
(Training/Testing)
N/A
5-fold Validation
(Training/Testing)
Training: 48
Testing: 36
5-fold Validation
(Training/Testing)

Ground Truth
Manual delineation by radiation oncologists
in the planning CT with reference to PET
Manual delineation by radiation oncologists
in the planning CT with reference to PET
Separate manual delineations by radiation
oncologists in CT and PET
Separate manual delineations by radiation
oncologists in CT and PET
Manual delineations by radiation oncologists
in CT
40% SUV threshold in PET with manual
adjustments in CT
Manual delineations by radiation oncologists
in PET
Semi-automatic connected thresholding
with manual adjustments
Manual delineations by radiation oncologists
in CT
40% SUV in PET with adaptive thresholding
in CT (50); Manual delineations by radiation
oncologists in CT (70)

DSC
0.79 ± 0.06
0.78
0.87 ± 0.05 (CT)
0.76 ± 0.09 (PET)
0.87 ± 0.03 (CT)
0.85 ± 0.06 (PET)
0.85 ± 0.08
0.64
0.86 ± 0.04 (CT)
0.87 ± 0.04 (PET)
0.71
0.86 ± 0.05

0.68 ± 0.23

* Planning CT & PET/CT: Planning CT registered to PET/CT was used instead of the CT from PET/CT as in the other previous works.
** Stereotactic Body Radiation Therapy (SBRT) is a treatment technique that delivers higher dose in each fraction with fewer fractions. It is
usually prescribed for relatively small and local tumors.
*** The study used two databases separately.

Similar multi-modality segmentation networks have been proposed for tumor sites
other than lung or modalities other than PET and CT. An alternative network structure was
tested in [58] where two V-Nets were cascaded to form a W-shaped network. The CT
images were taken as input for the first U-Net, from which the outputs and the PET images
were fed into the second U-Net. The argument for two sequential networks is that the
extracted knowledge from the first network would help regularize the second learning
process. However, in reverse, this would also mean that the performance of the second
network is limited by the first because the segmentation error would propagate. Guo et al.
[59], Havaei et al. [60], and Hou et al. [61] further investigated the effectiveness of different
parallel and sequential, respectively, network architectures for brain tissue segmentation.
In general, adaptations of machine learning in medical image segmentation have to
deal with challenges such as the class imbalance between normal and abnormal tissues,
the high computational demand due to the handling of 3D images, the scarcity of labelled
data for model training, and most importantly, the lack of validation. Many previous works
do not have a large enough database size (Table 2) to train a robust model and draw
statistically-significant conclusions. The parameters of the database (disease extent and
complexity, tumor location and complexity, etc.) and the training/validation/testing
protocols were also often not specified. A universal performance benchmark is difficult to
implement due to the limitations on medical data sharing. Many of these works chose to
demonstrate improved evaluation metrics, e.g., Dice similarity coefficient (DSC), over
selected previous similar methods. However, the validity of these comparisons is often
called into question when details on the database are not specified. In addition to
performance validation on a good and sizable database representative of the lung cancer
patient population, a clinical acceptability test is also crucial to testing the clinical usability
of any proposed method.

A.5 Radiomics
A.5.1 General Background
Radiomics refers to the extraction of quantitative data from medical images using data
characterization algorithms and the mining of these data for research or clinical decision
guidance. The image features extracted often quantifies characteristics of the intensity
patterns called biomarkers that are not readily apparent to the naked eye but are
hypothesized to reflect the underlying physiology and shown to improve diagnosis,
prognosis, treatment selection, and prediction of treatment response in many cancerrelated applications [62], [63]. For lung cancer radiotherapy specifically, radiomics has
been utilized to assess or predict overall survival, local or metastatic recurrence, radiation
treatment response, lung toxicity, as well as staging [64].
A typical workflow of a radiomics study consists of the following steps: image
acquisition,

image

segmentation,

feature

extraction,

feature

selection,

and

analysis/modeling [65]. In general, most radiomics studies are retrospective and use the
standard-of-care medical images, which are CT, PET, and sometimes MRI in lung cancer
treatment. While no sophisticated techniques are required, the specific image acquisition
protocols and parameters affect the stability of the radiomics features, the extent of which
has been widely discussed [66]. Following image acquisition, a pre-processing step is
often added to homogenize the images. In the next crucial step, a region of interest (ROI)
or volume of interest (VOI) is defined through image segmentation based on the study
objectives. This can be achieved manually, semi-automatically, or automatically [67].
While most studies in lung cancer radiomics investigated the tumors, the metastatic
lesions, or the entire area [68], there are some that analyzed the immediate peritumoral
region [69]–[71]. This is relevant to our feature selection step and will be discussed in
more detail in Section E.2. From the defined ROI or VOI, calculation of features can be

performed using a wide variety of algorithms and software. In theory, any mathematical
rules or formulas can be applied to an image to extract a corresponding feature. In practice,
guidelines for extracting standardized radiomics features are provided by the Image
Biomarker Standardization Initiative (IBSI) [72], and the implementation is usually
determined by the features available via the chosen extraction software. The types of
radiomics features mostly commonly used will be discussed in the next section. Because
of the availability of so many options, once the desired features were extracted, either as
single values or feature maps, a feature selection or dimension reduction step is
performed to narrow down the pool of candidates and rule out irrelevant features. This is
a multi-step process that is highly specific to the study objectives. Further detail about the
selection process for our work is presented in Section E.3. In the final step, a model is
built according to the specific endpoint of the research using the most relevant features.
In reality, feature selection and model development are often intertwined in an iterative
process. It is important to note that a prominent issue preventing the clinical application of
many radiomics-based methods is overfitting and the lack of generalizability [73], and
therefore appropriate internal and external validations are essential.

A.5.2 Types of Radiomics Features
When radiomics was first introduced in 2012 [63], radiomics features were mostly
semantic, a single characterizing number of a region of interest (ROI) such as volume,
shape, or heterogeneity. These features have been widely studied as biomarkers in aiding
clinical decision and outcome prediction. In recent years, the advent of computational
resources has enabled the extraction of voxel-wise radiomics features, providing us with
higher-order texture maps of the original image. Radiomics features in use nowadays can

be roughly divided into: 1) histogram-based, 2) texture-based, 3) model-based, 4)
transform-based, and 5) shape-based [74].
1) Histogram-based features describe the first-order statistical distribution of the pixel
or voxel intensity within the ROI. The most common members of this group include mean,
min/max, variance, percentiles, etc. SUVmax in PET is another example of a histogrambased feature. Some of the more sophisticated features can semantically describe the
shape or uniformity of the distribution, e.g., skewedness, entropy, and energy.
2) Texture-based features quantifies the spatial distribution of the neighboring pixels
or voxels on a higher order and incorporates spatial information through the usage of
matrices. Since the spatial context contained in these features are potentially useful in our
work, a brief description of some of the most commonly investigated texture features is
provided here, i.e., the Gray-Level Cooccurrence Matrix (GLCM), Gray-Level Run Length
Matrix (GLRLM), Gray-Level Size Zone Matrix (GLSZM), Neighboring Gray Tone
Difference Matrix (NGTDM), and Gray-Level Dependence Matrix (GLDM).
The GLCM quantifies the spatial relationships between pairs of pixels or voxels set
distances apart in predefined directions [75]. To help demonstrate the general principle of
how texture-based features are calculated, an illustrated example of GLCM calculation is
shown in Figure 3. For an image matrix I, the GLCM is defined as the matrix 𝑃(𝑖, 𝑗|, )
where the (𝑖, 𝑗) element is the number of times two pixels in the image I with gray levels 𝑖
and 𝑗 appear to be  pixels apart in the  direction. Once the matrix P is generated, its
normalized version p can then be used to calculate the GLCM features such as:
𝐺𝐿𝐶𝑀 𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 = ∑ ∑(𝑖 − 𝑗)2 𝑝(𝑖, 𝑗)
𝑖=1 𝑗=1

Figure 3. An example of GLCM calculation. Consider a 4x4 image I with discrete pixel values, i.e.,
gray levels from 0 to 3 (a), for distance  = 1 and direction  = 0𝑜 (for symmetrical GLCM, this
mean the pixels can be to either the left or right of the center pixel), the (0,0) and (0,1) elements
of GLCM P can be calculated as shown in (a) and (b), respectively. The fully calculated GLCM
matrix is shown in (c) and the normalized version p in (d).

GLRLM quantifies gray level runs, i.e., the number of consecutive pixels or voxels with
the same gray level [76]. Its corresponding features describe the properties of these runs,
e.g., gray-level and run-length uniformity, long- or short-run emphasis, etc. Similarly,
GLSZM counts the number of groups of neighboring pixels or voxels with the same gray
level [77]. NGTDM is the sum of differences between the gray level of a center pixel and
the mean gray level of its neighbors [78]. Some of the NGTDM features are colloquially
named, e.g., coarseness and complexity, since the quantities they represent are similar
to these image characteristics. In a similar fashion, GLDM counts the number of

neighboring pixels or voxels that are “dependent” on the center pixel or voxel, where
dependency is defined as a gray level difference within a predefined threshold [79].
3) Model-based feature extraction apply a specific mathematical or geometrical model
to the ROI to assess a specific quality of the ROI. For example, fractal analysis examines
the structural details under increasing magnification [80].
4) Transform-based features are obtained through the application of transformation
functions such as Gaussian, Gabor, wavelet, etc., most commonly as filters in the
preprocessing step. The Gaussian function, for instance, smooth the image and blur the
edge, while the Laplacian is an edge detector. Transform-based filters have been shown
to be effective as image preprocessing techniques prior to tumor segmentation [50] [81].
5) Shape-based features are geometric properties such as diameter, sphericity, etc.
They are not voxel-wise features but rather a single description of the ROI or VOI. Since
this type of features is produced from the tumor segmentation that we are trying to predict,
it is not applicable to our work.

A 5.3 Radiomics for Tumor Segmentation
To our knowledge, there has not been any previous work that used radiomics feature
images as inputs to a deep learning network for the purpose of tumor segmentation.
However, several methods have been proposed with radiomics and traditional machine
learning or other non-machine learning segmentation algorithms. Woods et al. used 4D
co-occurrence texture features and a four-layer artificial neural network to segment
malignant breast lesions on dynamic contrast-enhanced MRI [82]. For lung tumor
segmentation, Markel et al. tested a variety of features in combination with a decision tree
and the K-nearest neighbors (KNN) classifiers on PET/CT images [83]. More recently, a

radiomics-based segmentation method using a region growing algorithm was proposed
by Bundschuh et al [84]. While the goal of this study was to improve tumor visualization
on PET, not radiotherapy planning, they found that segmentation produced from entropybased features most closely matched the phantom studies. Furthermore, a study by
Torrents-Barrena et al. proposed a segmentation method for fetal and maternal anatomy
in MRI and ultrasound images through two parallel pipelines: one with radiomics and
support vector machine (SVM) and the other with deep learning and found that the
radiomics pipeline outperformed deep learning for some organs, while the opposite was
true for the others [85]. In addition, several studies emerged in the last few years that
demonstrated how integrating radiomics and deep learning could potentially improve the
task of classification for lung [86], head and neck [87], and prostate lesions [88].
With these advances in mind, we hypothesized that the incorporation of radiomics
feature images and deep learning could potentially improve the segmentation
performance for lung tumors.

A.6 Overview of Dissertation
A.6.1 Problem Statement and Purpose
The purpose of this study is to develop an effective method to automatically segment
lung tumors based on multi-modality medical images using machine learning and
radiomics.
Accurate differentiation between cancerous and normal tissues through images is
essential in the planning stage of external beam radiation therapy, so that the target and
the organs at risk are precisely defined to achieve maximum tumor cell killing and
minimum normal tissue damage. The most commonly employed imaging modalities in

radiotherapy for lung cancers are computed tomography (CT) and positron emission
tomography (PET). In the current clinical practice, the radiation oncologists rely on the
anatomical information from the former and the functional information from the latter, e.g.,
cell metabolism in the case of fluorodeoxyglucose (FDG)-PET, to create manual contours
of the tumors. This procedure known as volume delineation is time-consuming, and the
resulting contours are prone to inter- and intra-observer variability, one of the largest
contributors to uncertainty in the radiotherapy process. This variation in tumor contours
can have implications for not only the treatment outcome but also the comparison of
radiotherapy plans and protocols among physicians and institutions. An effective
automatic tumor segmentation method can potentially improve the clinical efficiency as
well as address the observer variability stemming from differences in subjective image
interpretation and improve the quality and consistency of lung cancer treatment.
Several strategies have been proposed for semi-automated or fully-automated tumor
delineation, or segmentation as the more commonly used terminology in computerized
image processing, using either single-modality or multi-modality images as input.
Variational methods, graph cut, machine learning, or a combination of these methods has
been proposed for a variety of anatomical sites. General limitations exist for non-machine
learning methods such as the need for user-input seeds for graph cut and the arbitrary
parameter selection in variational methods. While machine learning has shown great
promise in solving computer vision tasks including image segmentation, the specific issue
of lung tumor segmentation has not been sufficiently addressed. Not only does the
segmentation accuracy need to be improved from previous works and adequately
assessed using quantitative as well as clinical acceptability tests, but also should the
results be validated against a large and diverse dataset that reflects the broad range of
tumor size and case complexity encountered in the clinic. Previous machine leaning-

based frameworks showed promise but had not been able to produce sufficiently validated
results for clinical utilization.
In light of these shortcomings, we aim to develop an automatic segmentation
framework based on machine learning to utilize information from both PET and CT, the
modalities that are the current clinical standards for lung tumor radiotherapy planning,
optimizing the method with an expansive database representative of the lung cancer
patient population, and validating it against ground truth defined through the standard
treatment planning protocols. In addition to exploring dual-modality deep neural network
structures, this project seeks to improve the segmentation performance by applying
radiomics features as additional inputs. Other strategies such as tumor volume-based
stratification of the datasets will also be investigated to address issues encountered during
development and further improve performance. In addition to quantitative evaluation using
multiple similarity metrics and external validation against a public dataset, an evaluation
of the clinical acceptability of the segmentation results will be conducted with a group of
qualified radiation oncologists.

A.6.2 Specific Aims
Based on preliminary work, this goal will be achieved through 3 specific aims:
Specific Aim 1: Develop a deep learning neural network that utilizes dual-modality
images to automatically segment lung tumors for radiotherapy planning.
The goal of this specific aim is to establish a general framework from data curation
and preprocessing to network training and testing to postprocessing and evaluation. A
deep learning neural network will be constructed based on CNNs for 2 image inputs,
specifically PET and CT. Once our network is capable of producing meaningful
segmentation results, its performance will be evaluated through benchmark comparison

with a previously published deep learning network. Further measures will be
implemented to enhance the network performance, such as the transition from 2D to 3D
inputs, the optimization of the network parameters, as well as the adaptation of
alternative architectures if time and resources allow.
Specific Aim 2: Evaluate the potential of incorporating radiomics features as a third
input to the network to improve segmentation performance.
The network structure will first be modified to accommodate a third input of image
feature map in addition to the original two inputs: PET and CT. We plan to identify and
select useful features with the potential to improve the overall segmentation performance
from a pool of radiomics features. The reliability of these features will be evaluated to
assess the generalizability of our method.
Specific Aim 3: Improve segmentation performance by adding mechanisms to account
for challenging tumor features and conduct quantitative evaluations and clinical
acceptability tests of the segmentation results.
Based on preliminary results and previous studies, mechanisms will be introduced to
address the specific issues that impact the segmentation performance. We will investigate
the impact of tumor volume-based stratification of the dataset and adjustment in
training/validation strategy, conduct a clinical acceptability test where the clinicians choose
between a manual and a machine-generated contour in a blinded fashion, and assess our
models on an external database. In addit6ion, case studies will be conducted to identify
problematic tumor/tissue interfaces for future work in interface-specific improvement
techniques.

A.6.3 Innovation
This thesis proposes a multi-modality deep learning network structure to
simultaneously learn from planning CT, PET/CT dual-modality images, as well as the
higher-level image features (e.g., radiomics), for automatic lung tumor segmentation.
Based on preliminary results, a stratified training, validation, and testing strategy based
on the tumor volume will be adopted to improve the segmentation performance. To our
knowledge, no other work in automatic lung tumor segmentation has employed a stratified
training/validation/testing strategy or used voxel-wise radiomics image features as
additional inputs to improve segmentation performance.
Our access to a large and diverse patient database is essential to fully training,
validating, and testing the proposed network model. Unlike many of the previous works,
we will adhere closely to the current clinical protocols of lung cancer radiotherapy planning
by using the planning CT and the diagnostic PET/CT and ground truth segmentations
manually delineated by an experienced radiation oncologist. In addition to assessing the
quality of the segmentation results using both volume and surface metrics, to address the
clinical usability issue often seen in previous works, we plan to conduct a clinical
acceptability test where clinicians will be asked to choose between the manual
delineations and machine-generated segmentations. Furthermore, external validation will
be conducted with a public database. Both validation measures have not been done by
previous lung tumor segmentation studies.

B. Patient Database
B.1 Patient and Image Specifications
The patient database consists of the simulation CT and diagnostic PET images of 290
non-small cell lung cancer (NSCLC) cases, with a variety of tumor sizes (0.5 – 1036.4 mL
with median = 11.5 mL), stages (I: 152 cases, II: 22 cases, III: 93 cases, IV: 23 cases),
and locations, e.g., near mediastinum (110 cases), chest wall (164 cases), diaphragm (28
cases), etc. Patients were treated with either SBRT (166 cases) or conventionally
fractionated (124 cases) radiation therapy. All patients were treated in the VCU Health
Radiation Oncology clinic from 2008 to 2019. This study was approved by the institutional
review board.
All simulation CTs were acquired on a dedicated Big Bore CT scanner (Brilliance,
Philips Medical Systems, Best, The Netherlands) in a 512 x 512 matrix with an axial
resolution of 0.98 mm to 1.37 mm and a typical slice thickness of 3 mm (with 5 exceptions
ranging from 2 to 5 mm) as 4D-CTs in helical mode, with the respiratory cycle traced by
either the Varian Real-Time Position Management (RPM) (Varian Medical Systems, Palo
Alto, CA) or the Philips pneumatic bellows (Philips Medical Systems, Cleveland, OH).
Breath-hold with the Active Breathing Coordinator device (Elekta, Stockholm, Sweden)
was utilized for some patients who have large tumor motion and could comply with the
procedure. The majority of the PET images were obtained in a 128 x 128 matrix (with
seven 168 x 168) with an axial resolution of 3.91 mm to 5.47 mm and a slice thickness of
2 mm to 4.25 mm. While these images were acquired on a variety of PET/CT scanners:
52.5% GE Discovery 690, 29.3% GE Discovery LS, 12.5% GE Discovery ST (GE Medical
Systems, Cleveland, OH), and 5.7% others, all the PET scanners followed the same
institutional quality assurance (QA) guidelines. Typically, the images were acquired with
2.5 min per bed position and 8 bed positions per scan and reconstructed with ordered-

subset expectation maximization algorithm (OSEM) using 24 subsets. The noise
characteristic in the PET images from different scans did not appear to be different. The
PET images were typically obtained during staging within 6 weeks prior to the acquisition
of the simulation CTs in 83% of the cases. In some instances, the PET images were found
to be acquired up to 4 months before the simulation CT. Therefore, to ensure high quality
input data, we compared the anatomy on the simulation CT and the CT acquired along
with the PET on the PET/CT scanner and excluded the cases where significant anatomical
changes were found. In total, 16 cases were excluded. The main causes for exclusion
were development of atelectasis (6 cases) and drastic changes in tumor volume (4 cases).
For the majority of the cases, the planning CTs along with the contours used for the
clinical plans were acquired from Eclipse (Varian Medical Systems, Palo Alto, CA), while
some of the older cases were found on the Pinnacle archive (Philips Medical Systems,
Cleveland, OH). It is worth noting that the planning protocol in our clinic switched from
using the 30% breathing phase CT to the average intensity projection (AIP) in 2018. This
study did not investigate them separately due to limitations in data availability as well as
time and resources. The diagnostic PET/CTs were retrieved from the Philips IntelliSpace
picture archiving and communication system (PACS). All the images were exported to
MIM (MIM Software Inc., Cleveland, OH) for further processing.
All GTVs were initially delineated manually by the treating radiation oncologist at the
time in the simulation CT with the visual guidance of the corresponding PET/CT and
reviewed by an experienced radiation oncologist. Modifications were made mainly to
exclude metastatic lymph nodes and other metastatic diseases since our current main
focus is on the primary tumor only. Minor adjustments were also made in cases where an
ITV was contoured instead of a GTV.

B.2 Preprocessing
The simulation CT and the diagnostic PET were rigidly registered in MIM (MIM
Software Inc., Cleveland, OH) with the main focus on aligning the tumor volumes. In cases
where nearby lung pathologies obscured the tumor boundaries which made direct
alignment difficult, other anatomical landmarks in proximity to the tumor were included to
improve registration accuracy. The registered PET was then resampled to match the
resolution of the simulation CT.
As mentioned in the Lung Tumor Delineation and Observer Variability section,
deformable registration did not show significant benefit in improving the quality of manual
delineation. While its effect on machine learning-based automatic segmentation was
unclear, we were reluctant to use deformable registration due to its potential to alter usable
image features.
The DICOM images were preprocessed into 2D axial slices and 3D volumetric data
and stored in the TIFF and NRRD formats, respectively. The GTV delineations were
store in the DICOM RTst files as coordinates and was converted to masks with the
voxels within the tumor region labeled as 1. Voxel value normalization was performed on
the CT and PET images using the maximum and minimum voxel intensities of the CT
and PET images, respectively, across all patients.
The 290 image pair database was shuffled and divided into 162 training cases (162
pair of 3D volumes and 2403 pair of 2D slices), 59 validation cases (691 slices), and 59
testing cases (811 slices) by an approximately 3:1:1 ratio. Moderate data augmentation
was performed through rigid and affine transformation, i.e., horizontal flip, rotation in the
range of -20 to 20 degrees, and scaling by a factor of 0.8 to 1 to boost the training
database to 2-3 times its original size.

All codes were written in Python (Python Software Foundation. Version 3.6. Available
at http://www.python.org), using packages including SimpleITK [89], OpenCV [90], and
Pydicom [91]. For GTV-to-mask conversion, in-house algorithm was initially used, and
later on the package RT_Utils (https://github.com/qurit/rt-utils) was adopted.

C. Specific Aim 1
Develop a deep learning neural network that utilizes dual-modality images to automatically
segment lung tumors for radiotherapy planning.

C.1 Preliminary 2D Dual-Modality Network and Benchmarking
To our knowledge, there were no dual- or multi-modality deep learning software tools for
medical images readily available in the public domain [92], [93]. In this section of our
work, a novel dual-modality network architecture was constructed, the validity of which
was established through performance benchmark against a state-of-the-arts dualmodality segmentation method published closed to the time of our network development.

C.1.1 Constructing the Dual-Modality Segmentation Network
The fundamental requirement for our network architecture was its ability to utilize
information from two image modalities, PET and CT at this stage and provide the tumor
segmentation as a single output. To achieve that goal, we needed a base structure to build
on. Several previous works in multi-modality lung tumor segmentation (as mentioned in
Section A.3) chose U-Net to be the basis of their networks, justifiably, as its simple but
elegant architecture enables effective semantic image segmentation with relatively small
datasets and offers flexibility for adaptations and modifications.

Based on previous works and theory of how convolutional neural networks and the UNets specifically function [93], our segmentation network was constructed based on
concatenated subnetworks of 2D convolutional neural networks (CNNs) to simultaneously
learn from both the planning CT and the PET images (Figure 3). Note that the architecture
presented here was the one used for the preliminary work and benchmarking in this
section, a similar but updated 3D version with more details of the network architecture will
be presented in Section C.2.
The idea was to have two independent convolution arms for CT and PET so that the
image features most relevant to each modality can be extracted separately as the images
were downsampled and the resolution decreased. After each convolution block, the
extracted features from the CT and the PET branches are concatenated by the feature
channel and fed into a single deconvolution path at the corresponding resolution level
through skip connections. The purpose of concatenation is to provide the deconvolution
path with all the features available from both modalities at each resolution level and let the
trained weights determine which features are important. The deconvolution path ends with
an activation layer that produces a tumor/background probability map. The map was then
thresholded at 0.5 (i.e., the pixel has a higher than 50% chance of being the tumor) to
obtain the tumor mask. In training, to mitigate the class imbalance issue as the number of
background pixels far outweigh the tumor pixels, we used the Dice similarity coefficient
(DSC) as the training metric and negative DSC as the loss function.
The training process was monitored using the training and validation losses (both
calculated as DSC) and, to prevent overfitting, was stopped when the validation loss
appeared to plateau relative to the training loss. Each training session started with 40
epochs and continued in 10-epoch increments until the stopping conditions were met.

All codes were written in Python, utilizing the Keras library (Keras. Version 2.2) with
the Tensorflow backend (Google Research. Version 1.14). The models were trained on a
computer equipped with an NVIDIA GTX 980M GPU and an 8-GB memory. GPU
acceleration was supported by CUDA (NVIDIA. Version 10.1.) and CuDNN (NVIDIA.
Version 7.6.).

Figure 4. An illustration of our proposed dual-modality segmentation network architecture. The
arrows indicate the direction of forward data flow. The numbers on top of the images indicate the
resolution (first two) and the feature channel size (the third). Concatenation by the third
dimension, i.e., the feature channel, is performed every time the arrows from the 2 convolution
arms flow into the deconvolution path.

C.1.2 Performance Benchmark against a Selected Previous Work
A simple way to assess the validity of our proposed structure is through performance
comparison with a state-of-the-art automatic segmentation method. For that purpose,
another U-Net based architecture was adapted from a recently published article by Zhao
et al. [49] and trained and evaluated with our dataset. Zhao et al had access to a database

of 84 lung cancer patients and compared their results with a variety of traditional graphical
and variational methods as well as other deep learning-based methods, making it a
suitable candidate as a performance benchmark.
The adapted architecture (Figure 4) employs two independent U-Nets (without the final
activation layers) to extract the full feature maps from CT and PET and fuse them together
via elementwise sum. The fused feature map was taken as the input to the third U-Net,
which essentially acts as a feature fusion module that performs the segmentation task on
the combined information of CT and PET and produce a tumor mask.

Figure 5. An illustration of the previously proposed network architecture by Zhao et al. [49]. 
represents the elementwise sum operation.

Since we continued to build our dataset throughout this work, at the time when
benchmarking was performed, a smaller database of 213 cases was used. The
specifications of the database were similar to that of our eventual database with GTV sizes
from 0.6 to 1025.3 mL (median = 16.5 mL) and stages from I to IV. The dataset was
shuffled and divided into 129 training cases, 42 validation cases, and 42 testing cases by
a roughly 3:1:1 ratio. For clarification, all performance evaluation in the preliminary work

was conducted using only the validation cases, as the testing cases were being reserved
for the evaluation of the final model.
The DSC was calculated for each patient. Our model achieved a mean DSC of 0.772
 0.096, higher than the previous state-of-the-art method (DSC = 0.756  0.075). While it
was not conclusive that our model performs better (two-sample t-test, p = 0.22), the
segmentation results are at least comparable. A DSC histogram comparison (Figure 5)
indicates a decrease in patients with low DSC and an increase in DSC above 0.85.
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Figure 6. Histogram comparison of the DSC achieved by our preliminary network versus the
previous study. The bin number represents the upper limit of the DSCs in that bin.

Visual comparison of some segmentation results (Figure 7) demonstrated our
network’s potential to perform better than the previous work when there are more than
one lesions (or if the GTV is discontinuous on the axial slice) (Figure 7 (a-b)), or when
there is significant CT or PET signal heterogeneity within the GTV (Figure 7 (c-d)).

Figure 7. Case-specific comparison of the ground truth (Red), our work (Green), and previous
work (Yellow). Case (a) and (b) showed that our network was able to detect multiple masses that
were missed by the other network. Case (c) and (d) demonstrated our improvements in
segmentation accuracy in the presence of significant PET heterogeneity and atelectasis.

C.2 3D Dual-Modality Network
Both CT and PET images in our database were acquired in 3D. Voxel information in
adjacent slices provide additional inter-slice context that is missing when the images are
processed slice-by-slice. In many segmentation tasks, direct training with 3D images
were shown to achieve better accuracy at the cost of computational expense [94]. In this
section, we explored converting our network to 3D to improve segmentation
performance. In addition, for completeness of the work, single-modality networks using
only CTs as inputs were also constructed to investigate the contribution of PET images
to the dual-modality segmentation performance.

C.2.1 3D Data Preprocessing and Network Architecture
A framework to convert a network from 2D to 3D was presented in the article proposing
V-Net [48], the 3D adaptation of U-Net. Keras also provided many references on the
implementation of 3D CNNs, including an example of 3D image classification from CT
scans (https://keras.io/examples/vision/3D_image_classification/) that we referenced.
The conversion involved two main aspects: data preprocessing and network
architecture. While the 2D network took image slices in the TIFF format as inputs, the 3D
network (Figure 7) used the entire volumetric images in the NRRD format. Because each
scan had a different number of slices, the 3D volumes were resampled in the z-direction
so that the input shapes are uniform. Modifications in the network architecture were mainly
replacing the 2D functions with their 3D counterparts, e.g., Conv2D() to Conv3D() and
MaxPool2D() to MaxPool3D().

Figure 8. A diagram of the 3D dual-modality segmentation network architecture.

The challenges in this section of the work mostly arose from the increased need for
computational resources. While training took 3-4 hours for the 2D dual-modality models
on the computer with the NVIDIA 980M GPU, it would have taken significantly longer due
to the restricted batch size to save RAM space and the increased computational burden
of carrying out 3D convolution operations. Fortunately, we were able to utilize the Godel
computing cluster at the VCU High Performance Research Computing (HPRC) Core
Facility

(https://hprc.vcu.edu).

The

godel.hprc.vcu.edu

cluster

is

optimized

for

bioinformatics applications, with 1768 Intel and AMD 64 bit cores, each with at least 3 GB
RAM/core, 4.8 TB of total RAM, 17 TB of /home space, tmp space of at least 180 GB/node,
and 40 Gb/second Infiniband networking, 1.2TB of GPFS high-performance parallel file
system storage.

C.2.2 Implementation of surface similarity evaluation metrics for 3D volumes
Before discussing the segmentation results, we would like to introduce a couple of
surface evaluation metrics in addition to the Dice Similarity Coefficient (DSC) we had
been using so far for a clearer understanding of the network performance: the Hausdorff
Distance [95] and the mean Bi-directional Local Distance [96]. Whereas the DSC
measures the general volumetric similarity, the surface metrics enables visualization of
the global and local offset between the network-produced segmentation and the ground
truth.
The Hausdorff distance is a measure of mutual proximity between two shapes by
indicating the maximal distance between any point of one shape to the other. The
original form of Hausdorff distance, ℎ(𝐴, 𝐵), was formulated as a measure between the
set of feature points in model 𝐴 and those in model 𝐵, where
ℎ(𝐴, 𝐵) = max min‖𝑎 −𝑏‖
𝑎∈𝐴 𝑏∈𝐵

and the double brackets || || is a norm of the points of A and B. Hausdorff average, a
modified version, was shown to achieve superior performance over other variations [73].
The full algorithm of Hausdorff average was presented in Shapiro et al. The Python
library SciPy [97] was utilized for HD calculation in this work.
By definition, the HD is demonstrably sensitive to outliers. Therefore, we employed
the concept of the mean BLD. Whereas HD is a single value which represents the worstcase distance between two surfaces, BLD gives one local distance for each point in the
reference surface, i.e., the maximum BLD is the HD. BLD especially excels in areas of
folded or concave surfaces and has been used to assess the inter-observer variability in
the manual segmentation of lung tumors.[33] The mean BLD thus provides a measure of
the general distance between two surfaces. BLD is calculated in 3 steps [74]:
1. The forward minimum distance, FMinD, defined as the minimum distance from a
point on a reference surface R to all points on a test surface T:
𝐹𝑀𝑖𝑛𝐷(𝑝𝑟𝑒𝑓 , 𝑇) = 𝑑𝑚𝑖𝑛 (𝑝𝑟𝑒𝑓 , 𝑇) = min ||𝑝𝑟𝑒𝑓 − 𝑝𝑖 ||2
𝑝𝑖 ∈𝑇

where 𝑝𝑟𝑒𝑓 ∈ 𝑅.
2. The backward maximum distance, BMaxD, at 𝑝𝑟𝑒𝑓 on the surface R:
𝐵𝑀𝑎𝑥𝐷(𝑇, 𝑝𝑟𝑒𝑓 ) = max{𝑑|𝑑 = 𝑑𝑚𝑖𝑛 (𝑝𝑖 , 𝑅), 𝑑 = ||𝑝𝑖 − 𝑝𝑟𝑒𝑓 ||2 }
𝑝𝑖 ∈𝑇

3. Finally, 𝐵𝐿𝐷(𝑝𝑟𝑒𝑓 , 𝑇) = 𝑚𝑎𝑥{𝐹𝑀𝑖𝑛𝐷(𝑝𝑟𝑒𝑓 , 𝑇), 𝐵𝑀𝑎𝑥𝐷(𝑇, 𝑝𝑟𝑒𝑓 )}.
In-house algorithms were written for the mean BLD calculation.

C.2.3 Performance Comparison with 2D and Single-Modality Alternatives
In addition to comparing the 2D with the 3D network, in order to investigate the role of
PET in assisting segmentation, a single-modality network taking only CT images as input
was also built based on the classic U-Net and its 3D variant, V-Net. The diagram of the
2D network is not shown here as it is not significantly modified from the standard U-Net.

In volume segmentation, 2D networks where the images are input by slice have the
advantage of increased training sample size and faster training process. However, it only
looks at a single slice each time and thus may lose the features related to the inter-slice
correlation. 3D networks that learn from volumetric images, on the other hand, have fewer
training samples and are slower to train, but are able to make use of the additional interslice features, which may benefit the segmentation of lung tumors for a wide range of
tumor stages/sizes. Thus, both 2D and 3D versions of the segmentation network were
investigated in this work to choose the network architecture which has the best
performance.
The 3D PET & CT dual-modality model achieved mean DSC, HD, and mean BLD of
0.79 ± 0.10, 5.8 ± 3.2 mm, and 2.8 ± 1.5 mm, respectively. Comparatively, its 2D
counterpart produced 0.78 ± 0.15, 7.6 ± 4.7 mm, and 3.1 ± 1.3 mm. Those same metrics
for the single-modality CT-only models were 0.75 ± 0.16, 8.5 ± 5.8 mm, and 3.2 ± 1.4 mm
for 2D, and 0.77 ± 0.12, 7.6 ± 4.7 mm, and 2.9 ± 1.4 mm for 3D.
A case study on 2D vs. 3D (Figure 8) illustrates how inter-slice context can help
regulate the predicted segmentation and eliminate random outliers.

Figure 9. An example case comparing 2D versus 3D models. The top and bottom rows are the
segmentations in 3 neighboring slices predicted by the 2D and 3D models, respectively. Green
contour denotes the ground truth, and red denotes the network-predicted segmentation. The 3D
model promoted inter-slice continuity and thus avoided misidentifying possible lymph nodes in the
mediastinum in Slice 2.

Furthermore, Figure 9 shows how the dual-modality models achieved performance
gain over their single-modality counterparts by incorporating the PET images. In case A
(left), the PET showed activity in surrounding areas due to inflammation and tumor
boundary on CT is obscured due to atelectasis. Case B is a small tumor adjacent to the
chest wall with low to no PET signal. Visual assessment of these cases indicated that the
tumor boundaries were not well defined on either PET or CT due to high density lung
tissue (fibrosis or infectious changes) surrounding the tumor, or in some other cases the
presence of atelectasis with inflammatory changes on PET between the acquisition of PET
and CT made the accurate GTV definition impossible when the tumor boundary on CT
was unclear to begin with.

Figure 10. Two example cases comparing single- versus dual-modality models. Green contour
denotes the ground truth, and red denotes the network-predicted segmentation. The dualmodality model regulated the segmentation using the additional information from the PET images
to better define the GTV when the tumor boundary on the CT images-only was not clear.

Since the implementation of both 2D versus 3D and single- versus dual-modality
were intertwined with the volume-based stratification that we will introduce later on in
Section D.1, further discussion of these results will be included in Section D.2.

C.3 Optimization
To address the possibility of exploring alternative network architectures, while the
literature of other deep learning-based segmentation studies using alternative network
architectures were investigated, none stood out as a better alternative to U-Net. One
popular choice for single-modality segmentation is the convolutional residual networks
(CRNs), especially the ResNet [98]. The CRNs were created to deal with the problem of
vanishing gradient and degrading accuracy as the depth of a network increases [99].
CRNs essentially utilizes skip connections to redirect information from a shallower layer
to a deeper layer, enabling deep structures with minimal information degradation. Since

a deeper network theoretically has a higher capacity to learn, CRNs has the potential of
obtaining more accurate segmentation results. However, the deeper a network is, the
more parameters need to be trained, and therefore the more expensive it becomes
computationally. Adapting the network to dual-modality would further increase the
computational demand. Given that the established U-Net-based network had already
produced meaningful results and our limited time and resources, we decided to focus on
the current architecture and perform optimization through network functions and
parameters as well as post-processing algorithms, which are discussed in this section.

C.3.1 Network Functions and Parameters
There are many functions and parameters in a network that can be tuned to improve
segmentation performance, such as the number of convolution layers, the size of the
convolution kernels, the number of features extracted at each layer, the rate and type of
dropout functions, the choice of optimization algorithms and learning rate, etc. Without
fundamentally changing the network architecture, all of these factors can be experimented
with to achieve faster training or better results. While we investigated many different
combinations of these factors throughout the development of the network, it was by no
means comprehensive, as hyperparameter tuning in deep learning is an art of its own and
a highly iterative and arduous process. Here we will elaborate on two functions and
parameters that improved the network performance demonstrably: the optimizer and the
dropout layers.
An optimizer is an algorithm by which the learnable parameters, i.e., weights and
biases in a network are updated so as to minimizes an error function or a loss function
that is defined with certain metrics chosen to measure the network performance. The
two optimizers tested were the stochastic gradient descent (SGD) and Adam (Adaptive

Moment Estimation) [100] which is a updated version of stochastic gradient descent
method that is based on adaptive estimation of first-order and second-order moments.
According to Kingma et al., the method is "computationally efficient, has little memory
requirement, invariant to diagonal rescaling of gradients, and is well suited for problems
that are large in terms of data/parameters". We found that Adam converged much faster,
while SGD tended to oscillate and sometimes did not reach a DSC as high as Adam did
in the validation dataset (Figure 10). While there are arguments being made that SGD
generalizes better and reaches an improved final performance [101], [102], we did not
observe that effect, and therefore Adam was utilized for the remainder of this work.

Figure 11. Comparison between two training sessions using Adam (Grey) versus SGD (Red)
optimization algorithms.

The original dropout function was proposed to improve generalization and prevent
overfitting by randomly “dropping-out” or zeroing neurons during training [103]. Tompson
et. al. [104] argued that even after features from a certain central pixel were discarded,
the features from adjacent pixels might retain the strong correlations that may cause
overfitting. Therefore, they adopted the SpatialDropout function where the entire feature
channels were dropped instead of individual neurons, and found that their network
performance was improved, especially for small training sets. In our work, especially
when the stratified training strategy was employed on the 3D dataset (Section D.1),

overtraining was observed where the training DSC quickly reached 0.9, while the
validation DSC became stagnant just under 0.8, as shown in Figure 11. Replacing the
Dropout function with the SpatialDropout function appeared to slow down the DSC
increase in the training dataset and improve the final performance.

Figure 12. Comparison between two training sessions with the regular Dropout function (blue)
versus the SpatialDropout (pink) function.

C.3.2 Conditional Random Field Post-Processing
The output of the network is a probability map with voxel values from 0 to 1, with 1
labeling the predicted GTV. As shown in the example of the edge of a GTV in Figure 12,
most of the pixel values are close to either 0 or 1, so initially, the maps were simply
thresholded at 0.5 to produce the final segmentation. A threshold value of 0.75 was also
tested and was found to have negligible impacts on either the appearance of the
segmentations or the DSC.

Figure 13. Edge pixels of a predicted segmentation.

However, upon closer inspection, some network-predicted segmentations have small
“pockets” of mis-identified voxels (Figure 13) even after thresholding. To clean up these
voxels, the output tumor probability maps were passed through a Conditional Random
Field (CRF) filter [105]. Conditional random field (CRF) assesses areas of connectedness
and reassigns voxels to the most probable voxel class with consideration of its neighboring
voxels. Essentially, CRF looks at the surrounding voxel assignment and reassigns a voxel
to its most probable class based on conditional probabilities (given that the surrounding
voxels are class X, what is the probability this voxel is class Y). CRF has been shown to
eliminate small, isolated segments which are far from the main area of the same class.
While CRF post-processing did not have any significant impact of the DSC, it cleaned up
the segmentation and prevented the HD from being hijacked by outliers.

Figure 14. An example of a predicted segmentation with misidentified pixels and how a
conditional random field filter can help erase them without modifying the main segmentation
significantly.

C.5 Conclusion and Future Work
The preliminary dual-modality deep learning network we constructed was able to
segment lung GTVs from planning CT and diagnostic PET images, performing
comparatively, as assessed by the DSC, a state-of-the-art deep learning-based method
when validated on a subset of our internal database. The conversion from 2D data and
architecture to 3D, the optimization of network functions and parameters, and the
introduction of conditional random field postprocessing further boosted the segmentation
performance. The 3D dual-modality model outperformed its 2D and single-modality
counterparts according to both volumetric and surface evaluation metrics.
In future work, with more time and resources, it would be interesting to explore other
network architectures such as the previously mention CRNs. In addition, the recurrent

feature fusion network proposed by Bi et al. [54] is also of particular interest because of
its unique approach to progressively fuse different image modalities.

D. Volume-Based Stratification (Sub-Aim 3.1)
Evaluate the potential of stratified training/validation/testing strategies to improve
performance of the developed network.

D.1 Introduction
For clarification, this section of our work was originally a part of the Specific Aim 3 as
one of the mechanisms implemented to improve the segmentation performance.
However, throughout the course of this project, volume-based stratification of the
datasets was shown to be effective in various stages, so it makes sense to the author
that it should be placed here in its own section for the flow of the thesis.
After the initial segmentation network was trained and tested on all cases in Specific
Aim 1, a visual inspection of the low-performing cases as well as the DSC versus GTV
volume trends (Figure 15) showed that the initial network tended to perform worse at small
volumes and overestimated the size of small GTVs. This could be a result of the inherently
low resolution of PET as well as respiratory motion during the long acquisition period of
PET. Small tumors are more prone to displacement due to respiratory movements and the
signals from small tumors are more likely to be spread out in the neighboring voxels due
to volume averaging effect [106]. In fact, differences in the automated segmentation
performance of small and large lung tumors have been reported in a previous study using
CT only, and a focal loss function and an attention U-Net network were explored to
improve the segmentation accuracy for small tumors specifically [42]. Our intuition was to

encourage the network to treat small and large tumors differently and place a tighter
restriction on the size of small tumors and put less weights on the low PET signal in the
peripheral of the tumors. To that end, we investigated the effect of dataset stratification
based on tumor size.

Dice similarity coefficient (DSC)
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Figure 15. DSC vs volume for all patients. One case with a tumor volume of over 1000 mL was
not shown in the graph since it can be considered a geometric outlier and makes the graph
harder to read.

D.2 Stratified Training, Validation and Testing
A stratified training strategy based on the GTV volume was investigated. Separate
models were trained to segment large and small tumors so that the individual models can
better adapt to the image features specifically beneficial for the tumors in the different size
group. The dataset was stratified into 2 groups: the small GTVs below 25 mL (183 cases
with a median GTV of 7.0 mL) and the large GTVs above 25 mL (107 cases with a median
GTV of 86.0 mL). Each group was divided into its own training/validation/test subsets with
a ratio of approximately 3:1:1. The threshold volume for the stratification was chosen as
the estimated GTV volume to separate the cases with hypofractionation from the ones

with conventional fractionation. The choice also ensures adequate data size in each
training/validation/test subset.
In
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training/validation/testing combinations were evaluated, i.e., two stratified models were
trained for the small GTV subset, one was trained on all cases combined regardless of
GTV size and validated with the small GTV subset, the other was both trained and
validated with the small GTV subsets. Two stratified models were trained for the large
GTVs in similar fashion, i.e., one was trained on all cases combined regardless of GTV
size and validated with the large GTV subset, the other was both trained and validated
with the large GTV subsets. All combinations were shown in Table 1. The overall
performance metrics for the entire case population will be calculated as the combined
metrics from each test subset.
Paired t-tests were conducted in Microsoft Excel (Microsoft. Version 16.0.) to evaluate
the differences in metrics, with a two-tailed p-value < 0.05 indicating statistically significant
improvement. Comparisons were made between single- and dual-modality, 2D and 3D,
stratified and un-stratified, and single-modality unstratified vs. dual-modality stratified
networks.
Table 3. The mean Dice similarity coefficient (DSC), the Hausdorff distance (HD), and the mean
bi-directional local distance (BLD) between the ground truth segmentation and the segmentation
predicted by the 2D vs. 3D, single- vs. dual-modality networks trained/validated/tested with all
(non-stratified) vs. stratified data subsets.

Mean DSC
2D

3D

Training

Validatio
n&
Testing

SingleModality
(CT)

Dual-modality
(PET & CT)

SingleModality
(CT)

Dual-modality
(PET & CT)

All

All

0.749 ± 0.163

0.776 ± 0.140

0.772 ± 0.123

0.790 ± 0.103

All

Large

0.821 ± 0.073

0.841 ± 0.047

0.830 ± 0.087

0.854 ± 0.052

Large

Large

0.818 ± 0.080

0.830 ± 0.052

0.822 ± 0.074

0.837 ± 0.080

All

Small

0.679 ± 0.196

0.728 ± 0.170

0.714 ± 0.151

0.758 ± 0.128

Small

Small

0.784 ± 0.101*

0.797 ± 0.095*

0.795 ± 0.092*

0.821 ± 0.083*

0.798 ± 0.093

0.814 ± 0.083

0.808 ± 0.090

0.833 ± 0.071

Combined Overall

HD (mm)
2D

3D

Training

Validatio
n&
Testing

SingleModality
(CT)

Dual-modality
(PET & CT)

SingleModality
(CT)

Dual-modality
(PET & CT)

All

All

7.95 ± 5.39

6.37 ± 3.42

7.59 ± 4.73

6.84 ± 3.22

All

Large

12.12 ± 6.29

9.68 ± 3.99

10.89 ± 7.11

8.53 ± 3.79

Large

Large

11.79 ± 5.89

11.19 ± 4.14

11.95 ± 5.56

10.30 ± 4.20

All

Small

5.44 ± 2.02

4.84 ± 1.99

5.95 ± 2.81

4.56 ± 1.77

Small

Small

4.45 ± 1.59*

4.49 ± 1.58

4.53 ± 1.63*

4.41 ± 1.70

6.99 ± 5.08

6.28 ± 3.64

6.90 ± 3.67

5.95 ± 3.48

Combined Overall

Mean BLD (mm)
2D

3D

Training

Validatio
n&
Testing

SingleModality
(CT)

Dual-modality
(PET & CT)

SingleModality
(CT)

Dual-modality
(PET & CT)

All

All

3.93 ± 2.18

3.43 ± 2.06

3.59 ± 1.73

3.24 ± 2.52

All

Large

4.62 ± 2.36

3.85 ± 1.44

4.49 ± 2.11

3.83 ± 1.79*

Large

Large

4.71 ± 2.62

4.11 ± 1.43

4.65 ± 2.56

4.30 ± 1.50

All

Small

3.95 ± 2.23

3.08 ± 2.11

3.55 ± 1.81

3.16 ± 1.77

Small

Small

2.29 ± 0.91*

2.40 ± 1.01*

2.03 ± 0.63*

2.18 ± 1.07*

3.15 ± 1.96

2.94 ± 1.34

2.95 ± 1.18

2.80 ± 1.36

Combined Overall

These results were obtained using the corresponding testing data sets. The data in bold were
from the best performing stratified subsets and were used to calculate the combined overall
metric. * denotes results that are statistically significant (paired t-test, p < 0.05) compared with
their counterparts in the same cell blocks.

The stratified models produced significantly better overall metrics in all categories
except for the mean HD for the 2D and 3D dual-modality networks. A closer inspection of
the subsets showed that the small GTV subset appeared to clearly (p = 0.0005 to 0.05)
benefit from separate training, i.e., training and validation by the small GTV subsets. While
the 3D models do not appear to significantly improve the overall metrics, with the exception
of the improved DSC by the 3D dual-modality stratified model over its 2D counterpart (p =
0.05), the large GTV subsets achieved better HDs in 3D models (p = 0.05 for the model
trained by all cases and p = 0.03 for the model trained by the large training subset),
potentially due to a reduction in outliers.

D.3 Conclusion
Our proposed stratification strategy was shown to be especially effective in improving
segmentation accuracy for small GTVs. Separate training and validation of the small
GTV cases improved all three evaluation metrics for all 2D/3D single-/dual-modality
models. With the 3D dual-modality network architecture, stratification increased the
mean DSC of the small GTV test cases from 0.758 ± 0.128 to 0.821 ± 0.083 with
statistical significance.
It is important to note that the method conducted in this study was based on the GTV
volume from the manual contours. However, in clinical deployment of our method, the
volume is unknown since the GTV is yet to be segmented. We propose a two-step
process: In the first step, cases will be passed through a segmentation model trained
with all the training cases regardless of tumor volume to obtain the estimated GTV
volume. Then in the second step, those cases will be assigned to its corresponding
stratified model based on the volume calculated from its preliminary segmentation.

E. Specific Aim 2
Evaluate the potential of adding radiomics features as a third input to the network to
improve segmentation performance.

E.1 Introduction
As discussed in the introduction (Section A.5.3), no previous work was published on
using radiomics feature images as deep learning network inputs for tumor segmentation.
The goal of this section of our work is to investigate the validity of this approach and
whether one or more radiomics features can be identified to enhance the overall
segmentation performance achieved so far. To that end, we introduced a novel pipeline
unique to our needs to extract radiomics feature values from a customized VOI, to select
features with the most potential to improve the segmentation performance, to
incorporate these voxel-based feature images in building a predictive model, and to
evaluate these models against the ones built without radiomics inputs.
All radiomics features evaluated in this work were extracted from the planning CT
images, because they had been more widely studied than PET features and were found
to be more stable [74]. As we mentioned in the introduction, radiomics features are
sensitive to the imaging protocols and parameters. While all the planning CTs in our
internal database were acquired on a dedicated CT simulator, the origins of the diagnostic
PET/CTs were more heterogenous, which would in turn affect the quality of the PET
radiomics features, the extent of which is beyond the scope of this work.

E.2 Feature Extraction
Codes to extract the voxel-based radiomics feature maps were written in Python with
the open-source package Pyradiomics 2.2 [107]. The toolkit enables the extraction of both
the feature value (a single quantitative descriptor of the entire ROI/VOI) and the voxelbased feature map of 120 features including 19 first-order, 26 shape-based (both 2D and
3D), and 75 texture-based features from 5 commonly used feature classes: GLCM,
GLSZM, GLRLM, NGTDM, and GLDM.

As previously discussed, the shape-based

features rely on pre-established tumor segmentations and are therefore excluded from our
work. The complete list of the 104 features investigated are shown in Table 4, and further
information about their definitions and formulas can be found in the online documentations
for Pyradiomics (https://pyradiomics.readthedocs.io/en/latest/features.html). The feature
extraction process, especially for the voxel-based feature images, was computationally
intensive and was executed through Google Colab Pro+.
Table 4. List of radiomics features investigated in this work.
First Order Statistics

Imc1

LargeAreaEmphasis

10Percentile

Imc2

LargeAreaHighGrayLevelEmphasis

90Percentile

InverseVariance

LargeAreaLowGrayLevelEmphasis

Energy

JointAverage

LowGrayLevelZoneEmphasis

Entropy

JointEnergy

SizeZoneNonUniformity

InterquartileRange

JointEntropy

SizeZoneNonUniformityNormalized

Kurtosis

MCC

SmallAreaEmphasis

Maximum

MaximumProbability

SmallAreaHighGrayLevelEmphasis

MeanAbsoluteDeviation

SumAverage

SmallAreaLowGrayLevelEmphasis

Mean

SumEntropy

ZoneEntropy

Median

SumSquares

ZonePercentage

Minimum

GLRLM

ZoneVariance

Range

GrayLevelNonUniformity

NGTDM

RobustMeanAbsoluteDeviation

GrayLevelNonUniformityNormalized

Busyness

RootMeanSquared

GrayLevelVariance

Coarseness

Skewness

HighGrayLevelRunEmphasis

Complexity

TotalEnergy

LongRunEmphasis

Contrast

Uniformity

LongRunHighGrayLevelEmphasis

Strength

Variance

LongRunLowGrayLevelEmphasis

GLDM

GLCM

LowGrayLevelRunEmphasis

DependenceEntropy

Autocorrelation

RunEntropy

DependenceNonUniformity

ClusterProminence

RunLengthNonUniformity

DependenceNonUniformityNormalized

ClusterShade

RunLengthNonUniformityNormalized

DependenceVariance

ClusterTendency

RunPercentage

GrayLevelNonUniformity

Contrast

RunVariance

GrayLevelVariance

Correlation

ShortRunEmphasis

HighGrayLevelEmphasis

DifferenceAverage

ShortRunHighGrayLevelEmphasis

LargeDependenceEmphasis

DifferenceEntropy

ShortRunLowGrayLevelEmphasis

LargeDependenceHighGrayLevelEmphasis

DifferenceVariance

GLSZM

LargeDependenceLowGrayLevelEmphasis

Id

GrayLevelNonUniformity

LowGrayLevelEmphasis

Idm

GrayLevelNonUniformityNormalized

SmallDependenceEmphasis

Idmn

GrayLevelVariance

SmallDependenceHighGrayLevelEmphasis

Idn

HighGrayLevelZoneEmphasis

SmallDependenceLowGrayLevelEmphasis

Two rounds of feature extraction were performed for:
1) Feature Selection:
To identify the features with the most potential to improve the segmentation
performance, i.e., distinguish the tumoral tissue from its surroundings, it logically follows
to compare the feature values in the tumoral region with the ones in the peritumoral
region. Previous lung cancer radiomics studies in nodular classification [69], disease
spread prediction [70], and general methodology proposal [71] analyzed the peritumoral
region by dilating the manual tumor segmentations to create a rim or ring around the
GTV. The thickness of the rings ranged from 8 mm to 30 mm. For our work, we took the
rough average and created rings with a thickness of 20 mm by dilating the manual
segmentations. Feature values of the VOIs, i.e., the tumoral and peritumoral regions,
were then calculated for 104 features and the training dataset of 162 cases. Figure 8
shows an example of an CT image with its tumoral and peritumoral segmentations, as
well as the corresponding feature images for visualization. In the feature selection step,
only a single feature value is recorded from each VOI.

2) Network Input:
The feature images that were used as inputs to the deep learning network were
extracted using masks with all voxels labeled as True, hence including all voxels from
the CT images for voxel-wise feature extraction, with a kernel size of 3 x 3 and a bin
width of 25. This was performed on all 290 including the training, validation, and testing
datasets but only for the features selected for investigation in the next section, where
examples of them will be shown. This step was time-consuming, as voxel-based
extraction of the more complex feature classes such as GLCM often took hours for
cases with large image volumes.

Figure 8: An example of a CT image (a), the tumoral segmentation (b) and its corresponding
extracted GLDM Dependence Entropy image (c), the peritumoral segmentation (d) and its feature
image (e). The GLDM Dependence Entropy feature value within the tumoral region is 7.42 versus
4.88 in the peritumoral region.

E.3 Feature Selection with SelectKBest
In total, the values of 104 feature were calculated for the tumoral and peritumoral
regions of all 162 training cases. SelectKBest from the Python scikit-learn package [108]
was utilized to reduce the candidate pool and eliminate redundant features. As its name
suggests, SelectKBest works by removing all but the k highest scoring features based
on the chosen univariate statistical test, for which we employed the classic ANOVA Ftest, i.e., the function f_classif. F-test is a popular choice for classification tasks because
it calculates the ratio between variances of different groups to measure how distinctly
different they are. Essentially, features receiving higher F-Scores were better at
distinguishing between the tumoral and peritumoral regions.
With k=10, the features selected are listed in Table 5.

Table 5. Features selected by SelectKBest and ANOVA F-test from all cases. The features in
bold were chosen for investigation.

Feature Class
GLDM
NGTDM
GLSZM
GLCM
First Order
GLCM
GLCM
GLDM
First Order
GLRLM

Feature Name
DependenceEntropy
Coarseness
ZoneEntropy
MCC
RootMeanSquared
ClusterTendency
SumSquares
GrayLevelVariance
Variance
GrayLevelVariance

F-Score
430.6955
356.4575
345.1818
327.6402
311.2521
303.2483
268.8430
245.8914
245.8567
241.2145

In addition, because the stratified training/validation/testing strategy improved the
segmentation results, we were also interested in the features that would especially
benefit the large or the small GTV subsets (Table 6).

Table 6. Features selected by SelectKBest and ANOVA F-test from the large (top) and small
(bottom) GTV subsets. The features in bold were chosen for investigation.

Feature Class
GLDM
GLCM
GLCM
First Order
GLDM
GLCM
GLRLM
First Order
GLCM
First Order

Feature Name
DependenceEntropy
Correlation
SumSquares
Variance
GrayLevelVariance
SumEntropy
GrayLevelVariance
MeanAbsoluteDeviation
JointEntropy
RootMeanSquared

F-Score
312.7781
304.9258
295.4277
253.5094
253.3518
236.4214
231.0356
211.8688
201.1660
200.7453

Feature Class
First Order
First Order
First Order
NGTDM
First Order
GLSZM
GLCM
GLCM
First Order
GLSZM

Feature Name
Energy
TotalEnergy
RootMeanSquared
Coarseness
Median
ZoneEntropy
Correlation
Idmn
10Percentile
ZonePercentage

F-Score
350.4393
350.4393
331.8582
294.7814
268.6130
261.7176
244.7554
239.0278
221.9056
216.1771

The top two scoring features from each list were chosen for investigation. Visual
inspection of sample extracted feature images and analysis of the feature definitions
were conducted to further assess the suitability (Figure 16.a-b). It is interesting to
observe that the high-scoring features for the small GTVs were mostly the first order
features that are closely related to the local voxel value of the CT image. This is
consistent with the fact that most small GTVs were surrounded by the lung parenchyma,
and the hypothesis that the voxel intensity could be the one of the most discriminative
features.

Figure 16.a. Three of the six selected features with their sample voxel-based images and their
definitions. The planning CT that the features were extracted from, the PET, and the GTV mask
were also shown for reference.

Figure 16.b (Cont’d) Three of the six selected features with their sample voxel-based images and
their definitions.

GLDM Dependence Entropy was the highest scoring feature on both the all-case list
and the large-GTV list, so the third place feature on the all-case list was also tested. For
the small-GTV list, Total Energy is similarly defined as Energy, hence it was deemed
redundant and eliminated. The next place feature Root Mean Squared was selected
instead.
We recognize that this feature selection process was by no means thorough, as
studies on feature selection often employ multiple selection algorithms and more than
one round of dimension reduction. However, this section of our work was intended to be
a preliminary investigation into the validity of a novel method.

E.4 Incorporating Radiomics in Segmentation
E.4.1 Image Preprocessing and Normalization
The main challenge in preprocessing the voxel-based feature images is the
unbalanced distribution of voxel values for three of the features (Table 7): First Order
Energy, First Order Root Mean Squared (RMS), and NGTDM Coarseness.
Table 7. Specifications of the voxel values in each voxel-based feature image dataset.

Feature Name
GLDM Dependence Entropy
GLSZM Zone Entropy
GLCM Correlation
First Order Energy
First Order RMS
NGTDM Coarseness

Min
-3.20e-16
-3.20e-16
-0.92
0.00
0.00
0.00

Max
4.75
4.75
1.00
4.31e8
1.95e8
1.00e6

Mean
3.71
2.73
0.08
5.67e6
3.37e6
1.50e4

Median
3.78
2.85
0.07
8.22e5
1.76e5
0.17

The voxel values of GLDM Dependence Entropy, GLSZM Zone Entropy, and GLCM
Correlation were constrained by their definitions and relatively evenly distributed (Figure
17), so the standard normalization procedure was applied using the minimum and
maximum. However, the voxel values of the other three features: First Order Energy,
First Order RMS, and NGTDM Coarseness are heavily concentrated near the bottom of
the range (Figure 18). There are many reasons why data normalization is important in
machine learning, among which the most important ones: First, it scales each feature to
a similar range so that the network is not overly biased toward contributions from
features of higher values; Second, it reduces what is called an Internal Covariate Shift
where the distribution of the inputs to layers, especially those deep in the network,
change after each input, which cause the learning algorithm to forever chase a moving
target, and thus slowing down training [109]. Because the voxel value distributions for
First Order Energy, First Order RMS, and NGTDM Coarseness are so bottom-heavy,
simple normalization by the minima and the maxima would render the information in the

majority of the voxels trivial, while the issue of internal covariate shift remains. To
mitigate this problem, Log transformation was applied to the three feature images before
the standard normalization. The specifications of the voxel values post-transformation
are shown in Table 8. As seen in Figure 18, the voxel value distributions for First Order
Energy and First Order RMS became much more balanced. NGTDM Coarseness, on
the other hand, was still not ideally distributed. More sophisticated normalization
techniques might be necessary in future work.

Figure 17. Voxel value distribution of GLDM Dependence Entropy, GLSZM Zone Entropy, and
GLCM Correlation in the training datasets.

Figure 18. Voxel value distribution of First Order Energy, First Order Root Mean Squared, and
NGTDM Coarseness in the training datasets.
Table 8. Specifications of the voxel values in each voxel-based feature image dataset after log
transformation.

Feature Name
First Order Energy
First Order RMS
NGTDM Coarseness

Min
0.00
0.00
-7.24

Max
19.88
18.51
13.82

Mean
13.52
10.78
-1.67

Median
13.62
11.38
-1.77

E.4.2 Implementation and Results
A third convolutional arm was added to the 3D dual-modality network to learn from the
feature image input (Figure 19). Other network parameters remained the same. Models
were trained and tested for all six features with all cases as well as the stratified
training/validation/testing datasets. Training was conducted on the Godel cluster at the
VCU HPRC as well as Google Colab Pro+. The segmentation results, evaluated using the
DSC, HD, and mean BLD metrics, are shown in Table 9.

Figure 19. An illustration of our proposed multi-modality segmentation network architecture with 3
image inputs.

Table 9. The mean Dice similarity coefficient (DSC), the Hausdorff distance (HD), and the mean bi-directional local distance (BLD) of the segmentations predicted
by 3D networks using CT, PET, and radiomics feature images, trained/validated/tested with all (non-stratified) vs. stratified data subsets. The data in bold were
from the best performing stratified subsets and were used to calculate the combined overall metric. * denotes results that are statistically significant (paired t-test, p
< 0.05) compared with the counterpart without using radiomics features.

Mean DSC

Train

Val & Test

All
All
All
Large
Large
Large
All
Small
Small
Small
Combined Overall

PET & CT
0.790 ± 0.103
0.854 ± 0.052
0.837 ± 0.080
0.758 ± 0.128
0.821 ± 0.083
0.833 ± 0.063

First Order
Energy
0.803 ± 0.078
0.855 ± 0.055
0.839 ± 0.086
0.764 ± 0.104
0.826 ± 0.062
0.836 ± 0.059

First Order
RootMeanSquared
0.798 ± 0.145
0.839 ± 0.059
0.825 ± 0.117
0.773 ± 0.180
0.806 ± 0.194
0.818 ± 0.144

Feature Name
GLDM
DependenceEntropy
0.796 ± 0.086
0.868 ± 0.042*
0.824 ± 0.091
0.815 ± 0.073
0.829 ± 0.064
0.844 ± 0.056*

GLSZM
ZoneEntropy
0.798 ± 0.093
0.847 ± 0.063
0.833 ± 0.078
0.749 ± 0.134
0.820 ± 0.083
0.830 ± 0.075

GLCM
Correlation
0.805 ± 0.090
0.857 ± 0.054
0.820 ± 0.108
0.784 ± 0.098
0.829 ± 0.066
0.839 ± 0.062

NGTDM
Coarseness
0.783 ± 0.145
0.801 ± 0.109
0.814 ± 0.152
0.739 ± 0.123
0.764 ± 0.108
0.782 ± 0.124

GLCM
Correlation
6.65 ± 2.94
9.63 ± 4.09
9.95 ± 4.58
4.33 ± 1.33
3.94 ± 1.29
6.04 ± 2.32

NGTDM
Coarseness
7.42 ± 5.44
11.30 ± 5.90
10.92 ± 5.84
8.17 ± 6.00
8.77 ± 6.92
9.19 ± 5.94

GLCM
Correlation
2.48 ± 1.99
3.32 ± 1.74
4.09 ± 1.80
3.14 ± 1.65
1.87 ± 0.78*
2.40 ± 1.14

NGTDM
Coarseness
3.58 ± 4.41
5.83 ± 4.10
7.09 ± 4.07
3.90 ± 2.83
4.24 ± 3.15
4.82 ± 3.50

HD (mm)

Train

Val & Test

All
All
All
Large
Large
Large
All
Small
Small
Small
Combined Overall

PET & CT
6.84 ± 3.22
9.53 ± 3.79
10.30 ± 4.20
4.56 ± 1.77
4.41 ± 1.70
6.30 ± 2.47

First Order
Energy
6.97 ± 3.04
9.65 ± 3.81
9.70 ± 4.53
4.37 ± 1.60
4.16 ± 1.47
6.18 ± 2.33

First Order
RootMeanSquared
7.12 ± 2.32
10.03 ± 3.80
10.71 ± 4.77
5.19 ± 2.43
5.57 ± 2.83
6.98 ± 2.94

Feature Name
GLDM
GLSZM
DependenceEntropy
ZoneEntropy
6.74 ± 3.11
7.38 ± 4.01
8.92 ± 2.46
10.42 ± 3.69
10.37 ± 4.35
10.40 ± 3.60
4.10 ± 1.53
4.65 ± 1.68
4.09 ± 1.56
4.12 ± 1.48
5.87 ± 1.89
6.44 ± 2.29

Mean BLD (mm)

Train

Val & Test

All
All
All
Large
Large
Large
All
Small
Small
Small
Combined Overall

PET & CT
3.24 ± 2.52
3.83 ± 1.79
4.30 ± 1.50
3.16 ± 1.77
2.18 ± 1.07
2.80 ± 1.36

First Order
Energy
2.51 ± 1.96
3.36 ± 1.72
3.90 ± 1.61
3.00 ± 1.48
1.90 ± 0.71
2.44 ± 1.08

First Order
RootMeanSquared
3.17 ± 2.27
3.54 ± 1.70
3.90 ± 1.60
3.39 ± 1.68
2.54 ± 1.82
2.84 ± 1.78

Feature Name
GLDM
GLSZM
DependenceEntropy
ZoneEntropy
2.50 ± 1.94
2.60 ± 2.12
3.10 ± 1.25
3.57 ± 1.85
3.98 ± 1.41
3.69 ± 1.21
2.65 ± 1.34
3.22 ± 1.71
1.98 ± 1.05
1.97 ± 1.11
2.39 ± 1.13
2.56 ± 1.38

Analysis of Table 9 found statistically significant improvement in two results: The
addition of GLDM Dependence Entropy feature images to the model improved the
segmentation results from a DSC of 0.854 ± 0.052 to 0.868 ± 0.042 for large GTVs, and
therefore the combined overall DSC; and GLCM Correlation improved the results from a
mean BLD of 2.18 ± 1.07 to 1.87 ± 0.78 for small GTVs. Overall, these two features
appeared to produce better metrics, i.e., higher DSC and lower HD and mean BLD, in
other datasets as well, albeit these results were not statistically significant according to
the t-test. One notable issue for using the standard t-test to measure significance in this
case is the large standard deviations/variances in the HD and mean BLD values. It is
possible that the assessed data violated one of the t-test assumptions, e.g.,
nonnormality, the existence of outliers, etc., in which case a modified t-test or a Wilcoxon
rank-sum test may be more suitable tools. Further analysis should be conducted in
future work when a more comprehensive feature selection process is developed.
Upon closer inspection, case studies demonstrated how the addition of the GLDM
Dependence Entropy and GLCM Correlation feature images helped improving the tumor
segmentations for a large and a small GTV, respectively (Figure 20-21).
Furthermore, the benefits of employing the volume-based stratification technique still
applied even with the addition of radiomics features. There were a few exceptions, most
noticeably NGTDM Coarseness. In fact, NGTDM Coarseness performed poorly over all
metrics. This could potentially be a result of the normalization issue discussed in Section
E.4.1. The example in Figure 22 shows that the area of extreme values in the feature
image may have misdirected the network instead of helping it.

Figure 20. The automatic segmentation predicted by the model using PET and CT only (top row)
was improved to the one predicted by the model using the GLDM Dependence Entropy feature
images (bottom row) through the highlighting of the tissue structures that were not immediately
apparent on the CT. Green contour denotes the ground truth, and red denotes the networkpredicted segmentation.

Figure 21. A case study of how GLCM Correlation (bottom row) helped with improving the
segmentation by eliminating nearby normal tissue structures that was misidentified as part of the
GTV in the PET & CT only (top row) segmentation. Green contour denotes the ground truth, and
red denotes the network-predicted segmentation.

Figure 22. A case study where the introduction of NGTDM Coarseness feature images (bottom
row) appeared to cause the network to misidentify normal structures as the GTV as compared
with the PET and CT only model (top row). Green contour denotes the ground truth, and red
denotes the network-predicted segmentation.

E.3 Conclusion and Future Work
A pipeline for the extraction, selection, and incorporation of radiomics features into
the segmentation network was introduced in this section of our work. The validity of this
method was tested with 104 first- and higher-order radiomics features. We were able to
find two features that improved the model performance with statistical significance.
However, it was also demonstrated that either choosing the wrong features or
inadequately preprocessing the feature images can potentially degrade the
segmentation performance. Further investigation into using radiomics feature images for
lung tumor segmentation is warranted.

First, the candidate pool of radiomics features can be expanded. All features used in
this work were extracted with the original Pyradiomics package. Modifications can be
applied to the open-source codes to include more features introduced in subsequent
studies [75], [110]. In addition, while we chose to only include the CT features in this
study, PET radiomics has gained increasing traction in lung cancer-related applications
and are worth investigating in future studies. Furthermore, an interesting study by Amini
et al. proposed a methodology to extract the harmonized PET/CT features [111] that can
potentially be applied to our work to not only incorporate PET radiomics but also utilize
the information from the CT in the diagnostic PET/CT. In addition, within the
functionalities of Pyradiomics, built-in filters such as the Laplacian of Gaussian (LoG)
filter, the wavelet filter, the square filter, etc. can be applied prior to feature extraction as
a preprocessing step. Previous studies in NSCLC metastasis prediction [112] and tumor
subtype classification [113] demonstrated that filtered radiomics features made
significant contributions to their results. Since voxel-based feature extraction is one of
the most time-consuming processes in this work, we also propose for our future work the
implementation of GPU-powered feature extraction [114], [115] toolkits.
For a more sophisticated feature selection process, numerous methods and
combinations of methods have been employed in previous studies to reduce
dimensionality through eliminating features of high collinearity or high correlation with
each other and ranking the importance of features relative to the specific tasks [116],
[117]. In addition, one of the biggest hurdles in translating radiomics studies to clinical
practice is the robustness and reproducibility of the image features. As previously
mentioned, factors from acquisition techniques to respiratory motion to image
postprocessing can all influence the stability of radiomics features. Identifying and
eliminating unstable features is the key to improve the robustness of any radiomics
application. To that end, there are two main evaluation methods: 1) test-retest to assess

the temporal reproducibility of the features and 2) independent validation to address the
issue of overfitting and evaluates clinical generalizability [118]. Test-retest data, i.e.,
images of the same subject taken under similar acquisition conditions but some period of
time apart, are not routinely acquired in the clinical setting. To provide a clinicallyfeasible alternative, Larue et al. [119] found an effective substitute in CT images from
different breathing phases in a 4DCT image set. Per our clinical protocol, 4DCT is
acquired for lung tumor simulation, which provides us with a sizable “test-retest”
database. Independent validation from external sources offers valuable insights into the
cross-institutional generalizability of a method. A comprehensive feature selection
process will be developed as part of the future work including common metrics to assess
robustness and reproducibility such as the concordance correlation coefficients [120]
and the intraclass correlation coefficients [121].
Finally, of the remaining features, voxel-wise feature images will be extracted and
used to build models which will then be tested in a workflow that integrates the
stratification technique and the radiomics feature images, as shown in Figure 23.

Figure 23. Workflow to incorporate the volume-based stratification technique and the radiomics
feature images for lung tumor segmentation.

F. Specific Aim 3
Improve performance by adding mechanisms to account for challenging tumor features
and assess the performance of our method clinically.

F.1 Volume-Based Stratification (Moved to Section D)
F.2 Clinical Evaluation
F.2.1 Introduction
In this section of our work, we recruited a group of four radiation oncologists to
assess and modify the automatically-generated GTV segmentations and their manual
counterparts of a 20-case subset of our database.
The clinical usability of tumor segmentations in radiotherapy planning is ultimately
determined by the treating radiation oncologist. Even though we assessed the automatic
segmentations using both volumetric and surface metrics, geometric measures alone
may not translate to clinically meaningful endpoints [122], which is why a clinical
acceptability test of the automatically-produced segmentations by radiation oncologists
is essential. In practice, because of the numerous clinical duties already placed on
physicians, it is often difficult to recruit participants for evaluation studies. As a result, we
could not find any previous lung tumor automatic segmentation studies that implemented
physician review. There have been publications on the evaluation of segmentations of
other tumor sites [123], [124], organs-at-risk (OARs) [125], or the general methodologies
[34] that we were able to reference. The evaluation protocol was designed to incorporate
both a scoring scale and a modified Turing Test.

F.2.2 Implementation and Results
Four radiation oncologists who did not produce the original GTV segmentations
independently assessed the clinical usability of the segmentations predicted by the models.
The automatic segmentations used here were produced without radiomics but with
stratification. 20 cases in total (10 from each size group) were randomly chosen. To avoid
evaluation bias, both the automatic segmentations and their corresponding manual
ground truth segmentations were anonymized and shuffled to form the 40-case database
for review. The physicians were asked to categorize each segmentation as Accepted,
Accepted with Modifications, or Rejected. In the latter two scenarios they were also asked
to modify or recontour the GTV.
The evaluation guidelines sent to the physicians including the evaluation criteria and
step-by-step instructions are attached in Appendix B.1, and the unprocessed evaluation
results including reviewer comments in Appendix B.2.
On average, 91.25% of the manual vs. 88.75% of the automatic segmentations were
Accepted or Accepted with Modifications, with a higher percentage of the manual
segmentations being accepted as is (50% Accepted, 41.25% Accepted with Modifications
and 6.25% Rejected for manual vs. 18.75%, 70%, and 8.75% for automatic). The
distribution of the scores is shown in Figure 22.
The 20 cases selected for evaluation had a mean DSC of 0.820 ± 0.067 for automated
contour vs. manual ground truth. Comparatively, the mean DSCs were 0.924 ± 0.046
between the manual segmentations and their modified versions and 0.918 ± 0.040
between the automatic segmentations and their modified versions, indicating that the
extent of modifications were similar and relatively minor for both the manual and automatic
segmentations. In addition, the mean DSC between the modified automatic
segmentations and the corresponding manual ground truth contours were 0.829 ± 0.074,

similar to the results for automated versus ground truth manual contours for the evaluated
cases.

Figure 24. Percentage of cases (out of 20 Manual vs. Automatic segmentations): Accepted,
Accepted with Modifications, and Rejected according to reviews by four radiation oncologists
(distinguished by colors). The individual results were shown as well as the overall average in
each category.

Figure 25. An example of the modifications on the manual segmentation (top row) and the
automatic segmentation (bottom row). The axial, sagittal, and coronal views were displayed in the
left, middle, and right columns, respectively. The manual or automatic contours to be reviewed
are in green, and the contours of the same colors in the top and bottom rows were modifications
made by the same reviewers.

F.2.3 Discussion
Independent clinical evaluation by four radiation oncologists showed that the vast
majority of the segmentations produced through our method can be accepted for clinical
use with minor modifications. While the difference in acceptance-as-is rates may indicate
that the observers were able to identify that certain segmentations were of the machine
learning origin, quantitatively speaking, the observers did not modify the automatic
segmentations more than the manual ones. Furthermore, when modifications were made
on the automatic segmentations without reference to the ground truth, the observer
variations between the modified segmentations and the ground truth were comparable to
the variations between the automatic segmentations and the ground truth. This clinical
evaluation suggested that our method was able to produce clinically useful automatic lung
cancer segmentations with high consistency.
The disparity between ratings from different reviewers was somewhat expected, as
there was room for subjective interpretation in a scoring scale system. Furthermore, interobserver variability in lung GTV segmentation is well observed and one of the main
motivators of this study. It was, however, still interesting to see it clearly demonstrated in
some of the more difficult cases (Figure 24) and at the superior and inferiors ends of the
GTVs (Figure 25). Both the manual and automatic segmentations of the case shown in
Figure 24 was rejected by two out of four reviewers. In addition, with contours by the same
reviewer displayed in the same color, intra-observer variations can also be observed in
the modifications made to the manual and automatic segmentations of the same case.

Figure 26. One of the cases that received the worst ratings. The reviewed segmentations (top:
manual, bottom, automatic) were shown in green, and the modified segmentations were shown in
other colors.

Figure 27. Variations in the modified segmentations by different physician reviewers at the
superior end of a GTV.

F.3 External Validation
F.3.1 External Database
The external validation dataset is a 20-case subgroup of the NSCLC Radiogenomics
data collection [126]–[128] on The Cancer Imaging Archive (TCIA) [129]. TCIA is a
National Cancer Institute-funded public archive that hosts de-identified medical images of
cancer and offers free access of most of its collections to the public.
The NSCLC Radiogenomics data collection is comprised of the diagnostic CTs,
PET/CTs, tumor segmentations, and other radiogenomic data of a cohort of 211 patients.
Out of the 144 cases with tumor segmentations, 78 were evaluated for suitability.
Exclusion criteria include CT using contrast, local recurrence, image artifacts, and
extended interval between CT and PET/CT. From the remaining cases, 20 were chosen
with a variety of tumor sizes (1.1 – 361.8 mL with median = 20.0 mL) and stages (I: 11
cases, II: 4 cases, III: 5 cases, IV: 0 cases).
The preprocessing steps were similar to that of the internal dataset with the exception
of tumor segmentation-to-mask conversion. The segmentation file format was
incompatible with our original method, so 3D Slicer (https://www.slicer.org) [130] was
employed instead and the segmentations were exported as masks manually.

F.3.2 Implementation and Results
The models for all cases and the stratified models with the best performance on our
database, i.e., the model trained with all cases and validated with large GTVs, and the
model trained and validated with small GTVs only, were tested on the external dataset.
The models using only PET and CT as well as the ones with the additional feature image
inputs for all six selected features were also tested. All results are listed in Table 10.

Table 10. The mean Dice similarity coefficient (DSC), the Hausdorff distance (HD), and the mean bi-directional local distance (BLD) of the
segmentations predicted by unstratified and stratified models with and without radiomics. The data in bold are the best overall (unstratified vs.
stratified combined) result as evaluated by each metric.

Mean DSC

Train

Val & Test

All
All
All
Large
Small Small
Combined Overall

PET & CT
0.707 ± 0.083
0.601 ± 0.193
0.733 ± 0.115
0.667 ± 0.154

First Order
Energy
0.659 ± 0.146
0.579 ± 0.218
0.744 ± 0.151
0.662 ± 0.185

First Order
RootMeanSquared
0.678 ± 0.130
0.570 ± 0.222
0.751 ± 0.146
0.661 ± 0.184

Feature Name
GLDM
DependenceEntropy
0.651 ± 0.156
0.597 ± 0.212
0.738 ± 0.171
0.667 ± 0.192

GLSZM
ZoneEntropy
0.669 ± 0.137
0.562 ± 0.223
0.750 ± 0.157
0.656 ± 0.190

GLCM
NGTDM
Correlation Coarseness
0.686 ± 0.113
N/A
0.667 ± 0.187
N/A
0.738 ± 0.164
N/A
0.702 ± 0.175
N/A

HD (mm)

Train

Val & Test

All
All
All
Large
Small Small
Combined Overall

PET & CT
13.08 ± 5.90
19.54 ± 8.73
7.16 ± 2.30
13.35 ± 5.52

First Order
Energy
12.76 ± 7.32
19.06 ± 8.92
6.66 ± 1.97
12.86 ± 5.45

First Order
RootMeanSquared
12.69 ± 6.76
20.96 ± 9.30
6.48 ± 2.14
13.72 ± 5.72

Feature Name
GLDM
GLSZM
DependenceEntropy ZoneEntropy
12.5 ± 7.15
13.91 ± 15.05
18.83 ± 7.86
21.39 ± 9.05
6.36 ± 2.44
6.32 ± 2.19
12.6 ± 5.15
13.86 ± 5.62

GLCM
Correlation
12.27 ± 6.21
17.83 ± 6.70
6.70 ± 2.07
12.27 ± 4.39

NGTDM
Coarseness
N/A
N/A
N/A
N/A

GLCM
Correlation
6.95 ± 5.36
6.82 ± 3.10
2.96 ± 1.65
4.89 ± 2.37

NGTDM
Coarseness
N/A
N/A
N/A
N/A

Mean BLD (mm)

Train

Val & Test

All
All
All
Large
Small Small
Combined Overall

PET & CT
4.17 ± 3.20
6.48 ± 3.59
2.26 ± 1.01
4.37 ± 2.30

First Order
Energy
5.52 ± 4.80
9.54 ± 7.61
2.94 ± 1.59
6.24 ± 4.60

First Order
RootMeanSquared
5.61 ± 4.60
10.09 ± 3.79
2.80 ± 1.43
6.45 ± 2.61

Feature Name
GLDM
GLSZM
DependenceEntropy ZoneEntropy
5.97 ± 4.74
6.72 ± 5.06
7.14 ± 3.07
6.87 ± 3.23
3.02 ± 1.63
2.93 ± 1.53
5.08 ± 2.35
4.90 ± 2.38

F.3.3 Discussion
When tested on the external dataset, most of our models, with the exception of the
ones using the NGTDM Coarseness feature, produced GTV segmentations that had
reasonable appearances as judged by the author. However, comparison with the ground
truth segmentations provided by the TCIA database yielded significantly worse metrics
than our own internal database. Closer inspections revealed that there may be
fundamental issues with some of the TCIA dataset segmentations (Figure 27). The TCIA
dataset was created to facilitate radiogenomic and prognostic biomarker research, not to
enable automatic lung tumor segmentation for the purpose of radiotherapy planning.
There are a few important differences from our dataset:
1) The tumor segmentations in the TCIA dataset were automatically generated using
unspecified in-house algorithm for the computation of 3D quantitative image features.
Although the segmentations were reviewed by two radiologists, the criteria, albeit
unspecified, are most likely not the same as those necessary for radiation treatment
planning. To provide a preliminary assessment of the TCIA segmentations, our radiation
oncologist reviewed two cases and made manual segmentations according to the clinical
protocol for radiotherapy planning (Figure 28). Quantitative analysis of the two cases in
Figure 28 (a) and 28 (b) showed that when compared to the physician segmentations, the
automatic segmentations had DSCs of 0.874 and 0.860, respectively, but only 0.750 and
0.731 when compared to the TCIA segmentations.

Figure 28. Two case studies comparing the TCIA segmentation (green), the manual
segmentation by a radiation oncologist (yellow), and the automatic segmentation generated by
our model (red). The automatic segmentations in cases (a) and (b) were predicted by models
using GLCM Correlation and GLDM Dependence Entropy feature images, respectively.

2) All CTs were diagnostic CTs instead of simulation CTs and acquired on different
scanners with different scanning protocols and parameters. The scanning conditions were
similarly uncontrolled for the PET/CTs. External validation is an essential test of the
generalizability of any prediction model. The more similar the external dataset is to the
internal or development dataset, the more external validation assesses reproducibility. On
the other end of the spectrum, dissimilarities between the external and the internal
datasets assess the transportability of the model [131]. All these differences between the
external dataset and the internal/development dataset most likely impacted the validation
results negatively and measured the transportability more than the reproducibility against
ground truths that were questionable.

While these caveats limited the validity of the quantitative assessment results, it is
still encouraging to see that our models were able to produce reasonable segmentations
with an external database of PET and CT images, especially in the two case studies
where the automatic segmentations were shown to be more similar to the physician
segmentations than those provided by the TCIA dataset. To our knowledge, there are no
other publicly available databases with dual-modality PET and CT images of lung cancer
that also provide tumor segmentations, not to mention ones produced for radiotherapy
planning purposes. Therefore, in future work, there are two options that can be explored
for a more reliable external validation, both requiring physician inputs: 1) direct clinical
evaluation of the segmentations produced by our models, or 2) physician review and
modification of the ground truth segmentations from the TCIA database.

Figure 29. An example of a bad segmentation by the model using the NGTDM Coarseness
feature images. Green contour denotes the ground truth, and red denotes the network-predicted
segmentation.

F.4 Case Studies of Problematic Tumor/Tissue Interfaces
As discussed in the introduction, inter-observer variability in manual segmentation
varies depending on the tumor location and the type of tumor/surrounding tissue
interface. To assess how the automatic segmentation models perform at specific
interfaces between the tumors and the surrounding tissues and to explore directions for

future work, we visually examined the segmentation results with focus on cases
achieving one or more poor evaluation metrics. For each case, the segmentation by the
best performing model, i.e., stratified or unstratified and with or without radiomics
features, was presented.

F.4.1 High-Density Lung Tissue
The first type of problematic scenario observed in poor-performing cases is when the
tumor boundary is partially or fully obscured by high-density lung tissue possibly due to
fibrosis or infectious changes surrounding the tumor (Figure 30). This issue is further
complicated by the presence of high signal areas on PET due to inflammation rather
than tumoral metabolic activity. While we demonstrated in Figure 20 that certain features
such as the GLDM Dependence Entropy was able to help visualize the structures inside
of the high-density area and improve the segmentation performance in some cases, in
others, it still proved to be difficult to accurately differentiate tumor and the surrounding
area. As shown in the two cases in Figure 30, the automatic segmentations appeared to
be mainly dependent on the PET signals.

Figure 30. Two cases with high-density lung tissue surrounding the tumors. Both automatic
segmentations in case (a) and (b) were predicted by models using the GLDM Dependence
Entropy feature images. Green contour denotes the ground truth, and red denotes the networkpredicted segmentation.

F.4.2 Lymph Nodes in Proximity
The study perimeters were established early on to include only the primary tumors,
and therefore all ground truth manual segmentations were reviewed by a physician to
exclude the lymph nodes. However, in several instances, the network still picked up
some of the nearby lymph nodes, especially when there were pockets of high PET signal
nearby. It would be interesting to expand the study perimeters to include lymph nodes in
the ground truth in future work.

Figure 31. Two cases with lymph nodes in the proximity of the primary tumors. The automatic
segmentations in case (a) and (b) were predicted by models using the GLCM Correlation and
GLDM Dependence Entropy feature images, respectively. Green contour denotes the ground
truth, and red denotes the network-predicted segmentation.

F.4.3 Diaphragm
Around 10% of the cases in our database had tumors adjacent to the diaphragms. In
some of these cases, the automatic segmentation misidentified the diaphragm as part of
the GTV, most likely as a result of diaphragm having a similar density as the tumor on
CT and heightened metabolic activity and thus moderate amount of signal on PET.
While this only affected the few inferior slices in large GTVs, a bigger impact on small
GTVs, at least in terms of the DSC, was observed. For example, despite the significant
portion of the diaphragm misidentified as the tumor, the larger GTV in Figure 32(a) still
achieved an overall DSC of 0.928, while the smaller GTV in Figure 33 had a DSC of

0.764. Figure 32 also shows that some features such as the GLSZM Zone Entropy were
specifically better at distinguishing the tumor and the diaphragm.

Figure 32. Automatic segmentations predicted by two different models using (a) GLCM
Correlation and (b) GLSZM Zone Entropy feature images for a tumor adjacent to the diaphragm.
Green contour denotes the ground truth, and red denotes the network-predicted segmentation.

Figure 33. An example of a small tumor near the diaphragm. Green contour denotes the ground
truth, and red denotes the network-predicted segmentation.

F.5 Conclusion and Future Work
In this section, clinical evaluation inspired by the Turing Test was conducted with four
radiation oncologists to assess the clinical acceptability of the automatic segmentations
produced by the stratified models without using radiomics, and the majority of the
segmentations were accepted for clinical use with minor modifications. In addition, while
the results of externally validating our models with a TCIA database were not conclusive
due to potential issues with the ground truth definition, two case comparisons showed
that despite using external image data that were different from our internal data in many
aspects, the automatic segmentations by our models were consistent with the manual
segmentations by an experienced radiation oncologist. Lastly, we were able to identify
several specific tumor/normal tissue interfaces that can potentially be improved to further
enhance the segmentation performance.
So far, all quantitative evaluations of the automatic segmentations were performed
against the ground truth manual segmentations defined by a single radiation oncologist.
We recognize that potential bias exists in this framework. In future work, with access to
manual segmentations by multiple observers, an attractive alternative would be to create
a consensus ground truth using what is called the STAPLE algorithm, i.e., Simultaneous
Truth and Performance Level Estimation [132]. STAPLE is essentially a weighted voting
algorithm that combine a collection of segmentations in an iterative process into a
probabilistic estimate of the “true” segmentation, which can then be used to evaluate the
automatic segmentations. In addition, since one of the main goals of an automatic
segmentation method is to reduce the observer-related uncertainty, the inter-observer
variability can also be assessed using the consensus segmentation. If our method is
able to produce consistent tumor segmentations whose deviation from the consensus is
smaller than the mean observer variation, then our method is effective in reducing

observer-related uncertainty. Furthermore, STAPLE could potentially be adapted to
leverage the different automatic segmentations produced by the different models in our
work to generate an optimal segmentation.
As previously discussed, a more reliable external validation could be carried out with
physician inputs to modify the TCIA segmentations or with an alternative database if we
can identify and access one with segmentations better suited to our purpose.
There are a few options to be explored for the interface-related issues we identified:
1) For the high-density lung tissue that is pathological but not tumoral, several radiomics
features have already demonstrated their potentials to accurately identity the
tumor/tissue interface. Continued research into incorporating radiomics feature images
for segmentation is warranted. 2) For the nearby lymph nodes, as previously discussed,
we can consider expanding the study perimeters to include lymph nodes in proximity of
the primary tumor or to segment them separately. 3) For the diaphragm or other normal
tissues and structures, existing automatic segmentation methods for normal organs can
be applied to discourage or exclude them from consideration by the tumor segmentation
network.

G. Dissertation Conclusion
The goal of this dissertation was to develop an automatic framework based on deep
learning and dual-modality images for lung tumor segmentation, to investigate the
feasibility of incorporating radiomics and other mechanisms to improve the segmentation
performance, and to evaluate the developed methodology both quantitatively and
clinically.

To facilitate the development and validation of our methodology, an expansive
database of planning CTs, diagnostic PET/CTs, and manual tumor segmentations was
curated, and an image registration and preprocessing pipeline was established.
The first specific aim of this work was to build and optimize a dual-modality deep
learning network for lung tumor segmentation. A preliminary 2D convolutional neural
network was constructed to segment the GTVs from the planning CTs and the diagnostic
PETs and benchmarked against a state-of-the-art dual modality deep learning method.
The segmentation performance was optimized through the conversion to 3D, the tuning
of network functions and parameters, and the addition of conditional random field
postprocessing. The 3D dual-modality model outperformed all other models based on
the volumetric evaluation metric DSC and the surface metrics HD and mean BLD.
The second specific aim of this work was to investigate the potential of incorporating
radiomics feature images to improve the segmentation performance. We introduced a
workflow to extract quantitative feature values from the tumoral and peritumoral regions,
to select relevant features, to extract voxel-wise feature images, and to incorporate
those images as the third input in a modified segmentation network. Two radiomics
features, GLDM Dependence Entropy and GLCM Correlation, were determined to
enhance the segmentation performance with statistical significance.
The third and last specific aim was to further improve the method by adding
mechanisms to account for challenging cases and to evaluate the developed method
both quantitatively and clinically. Based on the observation that the initial segmentation
models performed worse for smaller tumors, we introduced a GTV volume-based
stratification technique to divide the training, validation, and testing datasets into their
respective small and large GTV subsets. With or without radiomics, the models trained
with the stratification strategy demonstrated improved segmentation performance,
especially for the small GTVs. In addition to the quantitative evaluation metrics, a clinical

acceptability test was conducted with multiple radiation oncologists, and the majority of
the automatic segmentations were found to be acceptable for clinical use with minor
modifications. Furthermore, external validation was carried out using a public database.
While the validation results were not conclusive, our models were able to produce
automatic segmentations in case studies that were comparable with the manual
segmentations by a radiation oncologist. Lastly, we identified several problematic
tumor/tissue interfaces that could potentially be improved in future work.
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Appendix A Best- and Worst-Performing Case Examples
In the following figures, green contour denotes the manually delineated ground truth, and
red denotes the network-predicted segmentation. The specifications of the 3D dualmodality model that produced the segmentation, i.e., the stratification scheme and the
radiomics feature used, are also listed. For the Hausdorff distance and the mean bidirectional local distance, examples were shown separately for the large and the small
GTVs, since these surface metrics were volume-sensitive. Note that the NGTDM
Coarseness models were excluded from this presentation, because they performed
significantly worse than all other models possibly due to inadequate normalization.

Appendix A.1 Dice Similarity Coefficient
•

Best-Performing Case:
Case ID: Subject X
DSC = 0.958
Training Dataset: Large
Validation and Testing Datasets: Large
Radiomics Feature: First Order Energy

•

Worst-Performing Case:
Case ID: CS009
DSC = 0.357
Training Dataset: All
Validation and Testing Datasets: All
Radiomics Feature: None

Appendix A.2 Hausdorff Distance
•

Best-Performing Large GTV Case:
Case ID: PX051
HD = 3.31 mm
Training Dataset: All
Validation and Testing Datasets: Large
Radiomics Feature: GLDM Dependence Entropy

•

Worst-Performing Large GTV Case:
Case ID: Subject I
HD = 26.51 mm
Training Dataset: All
Validation and Testing Datasets: All
Radiomics Feature: None

•

Best-Performing Small GTV Case:
Case ID: Subject X
HD = 0.78 mm
Training Dataset: Large
Validation and Testing Datasets: Large
Radiomics Feature: First Order Energy

•

Worst-Performing Small GTV Case:
Case ID: SX0102
HD = 11.21 mm
Training Dataset: Small
Validation and Testing Datasets: Small
Radiomics Feature: First Order Root Mean Squared

Appendix A.3 Mean Bi-directional Local Distance
•

Best-Performing Large GTV Case:
Case ID: PX051
Mean BLD = 1.35 mm
Training Dataset: All
Validation and Testing Datasets: Large
Radiomics Feature: GLCM Correlation

•

Worst-Performing Large GTV Case:
Case ID: Subject I
Mean BLD = 8.24 mm
Training Dataset: All
Validation and Testing Datasets: All
Radiomics Feature: None

•

Best-Performing Small GTV Case:
Case ID: SX0144
Mean BLD = 0.83 mm
Training Dataset: All
Validation and Testing Datasets: All
Radiomics Feature: GLDM Dependence Entropy

•

Worst-Performing Small GTV Case:
Case ID: SX0145
Mean BLD = 12.21 mm
Training Dataset: All
Validation and Testing Datasets: All
Radiomics Feature: First Order Root Mean Squared

Appendix B.1 Clinical Evaluation Guidelines
Project Description:
Manual lung cancer delineation for radiotherapy is time-consuming and suffers from observer variabilities that
can result in suboptimal tumor control or increased risk of treatment-related side effects. This study aims to
devise a robust and effective automatic lung tumor segmentation method using deep learning with the goal to
minimize the interobserver contouring variability and improve the clinical efficiency.
With the purpose of mimicking the current clinical workflow of lung GTV contouring, we developed a lung tumor
segmentation neural network that is capable of learning simultaneously from both the PET from the diagnostic
PET/CT and the simulation CT, with the manual GTV contour by an experienced radiation oncologist as the
ground truth. The network produces a tumor probability map that was post-processed to obtain the GTV
segmentation. In addition, we devised a tumor-volume-based training strategy that further improved the
network performance. Our network was trained/validated/tested on a dataset of 290 pairs of PET and CT from
the lung cancer patients treated at our clinic. The network-produced segmentations are evaluated both
statistically (DICE, Hausdorff Distance, and bi-directional local distance) and clinically (by you!).
Project Guidelines:
This part of the project is the clinical evaluation of 40 cases with GTV contours for lung cancer radiotherapy.
The GTV could be either manually contoured by a radiation oncologist or automatically segmented through the
machine learning method. All patients were anonymized and randomized to reduce bias. Each case should be
rated in terms of acceptability (accepted, accepted w/ modifications, or rejected), and the evaluator can modify
the contour if it is accepted with modifications, or completely redo if the contour was rejected.
MIM Server: SW Lung Segmentation
1. Patient Name/ID: Patient XX (01-40)

2. Select all modalities (CT, PET/CT PET, and PET/CT CT) and your assigned RTst Session X (1-6),
then Open Series

3. Evaluate the GTV contour according to the clinical protocols for lung radiotherapy:
•

Window/Level: mediastinum or lung (preset at lung)

•

PET/CT for reference, etc.

4. Record the results:
•

Open the spreadsheet SW Contour Evaluation Results.xlsx

•

Select Contour Acceptability: Accepted, Accepted w/ modifications, or Rejected

•

If Accepted w/modifications: modify the contour

•

If Rejected: recontour

•

Check the column in the spreadsheet Modified?

•

Please feel free to leave comments about any cases. I would very much appreciate your input (e.g.,
why you rejected the contour, what your thoughts were about the modifications that needed to be
made, general musings, etc.)

•

Example:

5. Save the session

Appendix B.2 Evaluation Results
Reviewer 1:

Patient ID
Patient 01
Patient 02
Patient 03
Patient 04
Patient 05
Patient 06
Patient 07
Patient 08
Patient 09
Patient 10
Patient 11
Patient 12
Patient 13
Patient 14
Patient 15
Patient 16
Patient 17
Patient 18
Patient 19
Patient 20
Patient 21
Patient 22
Patient 23
Patient 24
Patient 25
Patient 26
Patient 27
Patient 28
Patient 29
Patient 30
Patient 31
Patient 32
Patient 33
Patient 34
Patient 35
Patient 36
Patient 37
Patient 38
Patient 39
Patient 40

Accepted

Contour Acceptability
Accepted w/ modifications
x

Rejected

Modified?
x

Comments
some part not included

x

some part not included

x

x

Modified according to the layout on PET

x
x

x
x

x

x

x

x

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

x
x

x
x
x
x
x
x
x
x
x
x
x
x

Reviewer 2:

Patient ID
Patient 01
Patient 02
Patient 03
Patient 04

Contour Acceptability
Accepted
Accepted w/
Rejected
modifications
x

Modified?
x

x
x
x

x
x

Patient 05

x

x

Patient 06

x

x

x

x

x
x

x
x

x
x
x

x

Patient 07

x

Patient 08

x

Patient 09
Patient 10

x

Patient 11
Patient 12
Patient 13
Patient 14

x
x

Patient 15
Patient 16
Patient 17
Patient 18
Patient 19

x
x

x

Patient 20
Patient 21

x

Patient 22
Patient 23
Patient 24
Patient 25

x
x

x
x

x

x

x

x

x
x

x
x

Patient 26
Patient 27
Patient 28

Patient 29
Patient 30

x

x
x

x

x
x

Comments
pretty good. added slice inferior and several superior. Expanded GTV to
cover more of the peripheral spiculations/fluffiness. Erased off of rib
no change needed. Good GTV
overall good. Chased the projections a little more in my GTV
overall good, only minor adjustments on a few slices. Added one slice
superiorly
difficult to distinguish tumor from effusion inferiorly, but based on PET
inferior portion is effusion, so no need to add to GTV - which they didn’t.
Added about 2 cm to last inferior slice. No other changes…overall good
GTV on a tough target
overall good contour. Added 1 small slice superiorly. Very minor tweaks
to the peripherally of GTV. Probably would have been fine without.
Stylistic more than anything
Not an easy target to delineate, but with the use of PET, lung/mediastinal
window, I think it’s a good overall GTV. No change
Weird tumor. Little activity on PET, so not helpful. Overall, the GTV
encompasses what I would consider the tumor. No changes made
No change needed
SCV node should be covered…likely in a separate contour. Brachiocephalic
vessels were in GTV, I trimmed off of them. Ideally would definitely want
PET/CT registration for this contour. Difficult to assess tumor vs. collapsed
lung/atelectasis probably not a realistic target given large volume
Minimal changes
minimal changes - added 1 slice superior, more generous inferiorly
because difficult to assess effusion vs. tumor
good contour
a little generous in places, but acceptable especially since such a small
volume
good contour
good contour
overall good contour. Added some along the chest wall
overall good coverage of the primary solid tumor. Minor changes
added some to GTV to cover spiculations better. Erased one errant
contour that went along the chest wall where there was not tumor
overall good. Minor changes.
Definitely felt like a AI contour. GTV included descending aorta which I
cropped off of. Made lots of other changes. Probably should have started
from scratch, but just modified
periphery of tumor was not covered by GTV on some slices. I extended
made GTV larger - sup/inf. Extended to cover more chest wall
good contour - no change
made general expansion of GTV. Erased errant contour that extended
along peripheral vessel
added 1 slice sup, erased 1 slice inf. Otherwise no other significant issue
no issues. I would accept
maybe a little generous of a GTV, but difficult to determine tumor vs.
atelectasis, collapse, etc. so I think it is a reasonable GTV. Would not
change
minor changes
minor changes, stylistic and probably wasn't needed

Patient 31
Patient 32
Patient 33
Patient 34

x
x
x
x

x
x
x

Patient 36
Patient 37
Patient 38

x
x
x

x

Patient 39

x

x

Patient 40

x

x

no change
added 1 slice sup. Enlarged GTV on the periphery on a couple slices
very minor changes. Probably would have been acceptable as is
added 1 slice inf. Covered the lateral aspect 1 slice before original
contour
really tight GTV around the tumor, I was tempted to extend slightly to
cover the equivocal hazy area outside the solid component, but ultimately
left it as is
minor changes. Probably could have been left alone
added 1 slice sup. Extended contour into the carina one slice earlier
GTV was too small. Did not cover solid component of tumor. Also
extended into chest wall further
inferior two slices include dome of liver. Erased. Otherwise, no other
changes
minor changes to the superior/anterior portion of the tumor.

Patient 35

x

Modified?

Comments

x

Added some expansion and smoothing between slices
Good inclusion of axial inferior and superior slices with haziness
(representing the lower and upper limits of disease)
Excellent distinction of tumor and vessel
Missing obvious tumor in portions of GTV

x

Reviewer 3:

Patient ID
Patient 01
Patient 02
Patient 03
Patient 04
Patient 05
Patient 06
Patient 07
Patient 08
Patient 09
Patient 10
Patient 11

Contour Acceptability
Accepted
Accepted w/
Rejected
modifications
x
x
x

Patient 19
Patient 20
Patient 21
Patient 22
Patient 23
Patient 24
Patient 25
Patient 26
Patient 27

x

x
x

x
x
x

x

x
x

Patient 12
Patient 13
Patient 14
Patient 15
Patient 16
Patient 17
Patient 18

x
x

x

x

x

x

x

x

x
x
x

x

x
x

x
x
x
x
x
x
x
x
x

x
x

x

x
x
x
x
x
x
x

Very tight contours with tumor slightly outside GTV on some slices
Way too generous in some areas, not generous enough in others
**Wrong lesion contoured; PET avid lesion more superior**
Perfect
Way too generous in some areas, not generous enough in others
Good GTV coverage, expanded margins slightly, added inferior and
superior slices
Tough case with differences between PET and CT Sim, infection at time of
PET?
All GTV was covered, but decreased total coverage based on PET
Good coverage
Good coverage
Added one superior slice
Very small modifications
Tough case with? progression since PET, would benefit from PET/CT sim
fusion
Very small modifications, mostly superior
would benefit from PET/CT sim fusion
Tough case, likely infection showing on PET, contours missing some GTV
Good coverage, but contours too tight
Good coverage, but contours too tight
Very small modifications, mostly superior
Small modifications, missing superior coverage
Not great coverage
**Missing mediastinal LN coverage** Otherwise, small modifications,
missing inferior slice

Patient 28
Patient 29
Patient 30
Patient 31
Patient 32
Patient 33
Patient 34
Patient 35
Patient 36
Patient 37

x
x

x
x

x
x
x

x

x
x

x
x

x
x

x
x

x

Patient 38
Patient 39

x
x

Patient 40

x

x
x
x

Tough case
Difficult to distinguish pleural fluid and tumor
Good coverage
Over-coverage
**Wrong lesion contoured; PET avid lesion more superior**
Small modifications
Great coverage
Good coverage, but contours too tight
Good coverage, but contours too tight; GTV covers some esophagus at
inferior
Poor coverage of GTV in middle of tumor
Starts covering into liver at inferior slice; Otherwise, small modifications
due to tight contours
Tough case, would benefit from PET/CT sim fusion, small modifications
made

Reviewer 4:

Patient ID
Patient 01
Patient 02
Patient 03
Patient 04
Patient 05
Patient 06
Patient 07
Patient 08
Patient 09
Patient 10
Patient 11
Patient 12
Patient 13
Patient 14
Patient 15
Patient 16
Patient 17
Patient 18
Patient 19
Patient 20
Patient 21
Patient 22
Patient 23
Patient 24
Patient 25
Patient 26
Patient 27
Patient 28
Patient 29

Contour Acceptability
Accepted
Accepted w/
Rejected
modifications
X
X
X
X
X
X
X
X

Modified?

Comments

X

Tweaked edges, added a slice

added a slice sup and inf, tweaked edges

Was able to adjust the initial contour, but needed a lot of changes
Contour is fine, though area contoured not PET avid, PET avid area in
lateral lung.
Good

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

Need a number of tweaks to edges

trimmed off some edges
only one or two minor tweaks
Good.. Just added one slice sup and inf
A few minor changes
moderate modifications
pretty good, minimal changes
moderate changes
moderate changes
minor changes
some changes, overall pretty good
minor changes
volume felt ok, just shifted a bit off target, so tweaked
good, minor changes
hard to contour without actual fusion, would fuse for real planning
hard to contour without actual fusion, would fuse for real planning

Patient 30
Patient 31
Patient 32

X
X

Patient 33
Patient 34
Patient 35
Patient 36
Patient 37
Patient 38
Patient 39
Patient 40

X
X
X
X
X
X
X
X

X
X

X
X
X
X
X
X
X
X

minor changes
*tweaked contoured lesion, though no PET-avid, small avid lesion not
contoured
very minimal tweaks
minor changes
very minimal tweaks
minor changes
minor changes
minimal changes
took off bottom slice, added slice superiorly, tweaked a few edges
needed a good bit of tweaking

